Main Menu

Publications

Publications Highlights View all by category

Types of Publications


Journal Articles

Rischin, D. Harrington, K.J. Greil, R. Soulières, D. Tahara, M. de Castro, G. Psyrri, A. Braña, I. Neupane, P. Bratland, Å. Fuereder, T. Hughes, B.G. Mesía, R. Ngamphaiboon, N. Rordorf, T. Ishak, W.Z. Hong, R.-. Mendoza, R.G. Jia, L. Chirovsky, D. Norquist, J. Jin, F. Burtness, B. (2022). Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048. , Vol.128, p. 105815.  show abstract

Lee, R.J. Wysocki, O. Zhou, C. Shotton, R. Tivey, A. Lever, L. Woodcock, J. Albiges, L. Angelakas, A. Arnold, D. Aung, T. Banfill, K. Baxter, M. Barlesi, F. Bayle, A. Besse, B. Bhogal, T. Boyce, H. Britton, F. Calles, A. Castelo-Branco, L. Copson, E. Croitoru, A.E. Dani, S.S. Dickens, E. Eastlake, L. Fitzpatrick, P. Foulon, S. Frederiksen, H. Frost, H. Ganatra, S. Gennatas, S. Glenthøj, A. Gomes, F. Graham, D.M. Hague, C. Harrington, K. Harrison, M. Horsley, L. Hoskins, R. Huddar, P. Hudson, Z. Jakobsen, L.H. Joharatnam-Hogan, N. Khan, S. Khan, U.T. Khan, K. Massard, C. Maynard, A. McKenzie, H. Michielin, O. Mosenthal, A.C. Obispo, B. Patel, R. Pentheroudakis, G. Peters, S. Rieger-Christ, K. Robinson, T. Rogado, J. Romano, E. Rowe, M. Sekacheva, M. Sheehan, R. Stevenson, J. Stockdale, A. Thomas, A. Turtle, L. Viñal, D. Weaver, J. Williams, S. Wilson, C. Palmieri, C. Landers, D. Cooksley, T. ESMO Co-Care, Dive, C. Freitas, A. Armstrong, A.C. (2022). Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital. , Vol.6 (6), p. e2100177.  show abstract

Patin, E.C. Dillon, M.T. Nenclares, P. Grove, L. Soliman, H. Leslie, I. Northcote, D. Bozhanova, G. Crespo-Rodriguez, E. Baldock, H. Whittock, H. Baker, G. Kyula, J. Guevara, J. Melcher, A.A. Harper, J. Ghadially, H. Smith, S. Pedersen, M. McLaughlin, M. Harrington, K.J. (2022). Harnessing radiotherapy-induced NK-cell activity by combining DNA damage-response inhibition and immune checkpoint blockade. Journal for immunotherapy of cancer, Vol.10 (3).  show abstract

Bozhanova, G. Hassan, J. Appleton, L. Jennings, V. Foo, S. McLaughlin, M. Chan Wah Hak, C.M. Patin, E.C. Crespo-Rodriguez, E. Baker, G. Armstrong, E. Chiu, M. Pandha, H. Samson, A. Roulstone, V. Kyula, J. Vile, R. Errington-Mais, F. Pedersen, M. Harrington, K. Ono, M. Melcher, A. (2022). CD4 T cell dynamics shape the immune response to combination oncolytic herpes virus and BRAF inhibitor therapy for melanoma. Journal for immunotherapy of cancer, Vol.10 (3), pp. e004410-?.  show abstract

Gillison, M.L. Blumenschein, G. Fayette, J. Guigay, J. Colevas, A.D. Licitra, L. Harrington, K.J. Kasper, S. Vokes, E.E. Even, C. Worden, F. Saba, N.F. Docampo, L.C. Haddad, R. Rordorf, T. Kiyota, N. Tahara, M. Jayaprakash, V. Wei, L. Ferris, R.L. (2022). Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141. Oncologist, Vol.27 (2), pp. E194-E198 (5).

Nenclares, P. Harrington, K.J. (2022). Management of Head and Neck Mucosal Melanoma. Oral and maxillofacial surgery clinics of north america, Vol.34 (2), pp. 299-314.

Castelo-Branco, L. Tsourti, Z. Gennatas, S. Rogado, J. Sekacheva, M. Viñal, D. Lee, R. Croitoru, A. Vitorino, M. Khallaf, S. Šušnjar, S. Soewoto, W. Cardeña, A. Djerouni, M. Rossi, M. Alonso-Gordoa, T. Ngelangel, C. Whisenant, J.G. Choueiri, T.K. Dimopoulou, G. Pradervand, S. Arnold, D. Harrington, K. Michielin, O. Dafni, U. Pentheroudakis, G. Peters, S. Romano, E. (2022). COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE). , Vol.7 (3), p. 100499.  show abstract

Feeney, L. Hapuarachi, B. Adderley, H. Rack, S. Morgan, D. Walker, R. Rauch, R. Herz, E. Kaye, J. Harrington, K. Metcalf, R. (2022). Clinical disease course and survival outcomes following disease recurrence in adenoid cystic carcinoma with and without NOTCH signaling pathway activation. Oral oncology, Vol.133, pp. 106028-106028.

Hardman, J.C. Harrington, K. Roques, T. Sood, S. Jose, J. Lester, S. Pracy, P. Simo, R. Repanos, C. Stafford, F. Jennings, C. Winter, S.C. Wheatly, H. Homer, J. Kumar, B.N. Paleri, V. (2022). Methodology for the development of National Multidisciplinary Management Recommendations using a multi-stage meta-consensus initiative. , Vol.22 (1), p. 189.  show abstract

Evgin, L. Kottke, T. Tonne, J. Thompson, J. Huff, A.L. van Vloten, J. Moore, M. Michael, J. Driscoll, C. Pulido, J. Swanson, E. Kennedy, R. Coffey, M. Loghmani, H. Sanchez-Perez, L. Olivier, G. Harrington, K. Pandha, H. Melcher, A. Diaz, R.M. Vile, R.G. (2022). Oncolytic virus–mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice. Science translational medicine, Vol.14 (640).  show abstract

Samson, A. West, E.J. Carmichael, J. Scott, K.J. Turnbull, S. Kuszlewicz, B. Dave, R.V. Peckham-Cooper, A. Tidswell, E. Kingston, J. Johnpulle, M. Da Silva, B.L. Jennings, V.A. Bendjama, K. Stojkowitz, N. Lusky, M. Prasad, K.R. Toogood, G.J. Auer, R. Bell, J. Twelves, C.J. Harrington, K.J. Vile, R.G. Pandha, H. Errington-Mais, F. Ralph, C. Newton, D.J. Anthoney, A. Melcher, A.A. Collinson, F. (2022). Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anti-Cancer Immunity in Patients. Cancer immunology research, .  show abstract

Burtness, B. Rischin, D. Greil, R. Soulières, D. Tahara, M. de Castro, G. Psyrri, A. Brana, I. Basté, N. Neupane, P. Bratland, Å. Fuereder, T. Hughes, B.G. Mesia, R. Ngamphaiboon, N. Rordorf, T. Wan Ishak, W.Z. Ge, J. Swaby, R.F. Gumuscu, B. Harrington, K. (2022). Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score. , Vol.40 (21), pp. 2321-2332.  show abstract

Rack, S. Feeney, L. Hapuarachi, B. Adderley, H. Woodhouse, L. Betts, G. Burghel, G.J. Harrington, K.J. Metcalf, R. (2022). Evaluation of the Clinical Utility of Genomic Profiling to Inform Selection of Clinical Trial Therapy in Salivary Gland Cancer. Cancers, Vol.14 (5).  show abstract

Melake, M.J. Smith, H.G. Mansfield, D. Davies, E. Dillon, M.T. Wilkins, A.C. Patin, E.C. Pedersen, M. Buus, R. Melcher, A.A. Thway, K. Miah, A.B. Zaidi, S.H. Hayes, A.J. Fenton, T.R. Harrington, K.J. McLaughlin, M. (2022). OX40 and 4-1BB delineate distinct immune profiles in sarcoma. , Vol.11 (1), p. 2066050.  show abstract

Ng, W.T. Soong, Y.L. Chan Ahn, Y. AlHussain, H. Choi, H.C. Corry, J. Grégoire, V. Harrington, K.J. Hu, C.S. Jensen, K. Kwong, D.L. Langendijk, J.A. Le, Q.T. Lee, N.Y. Lin, J.C. Lu, T.X. Mendenhall, W.M. O'Sullivan, B. Ozyar, E. Pan, J.J. Peters, L.J. Poh, S.S. Rosenthal, D.I. Sanguineti, G. Tao, Y. Wee, J.T. Yom, S.S. Chua, M.L. Lee, A.W. (2021). International Recommendations on Re-irradiation by Intensity-modulated Radiotherapy for Locally Recurrent Nasopharyngeal Carcinoma. International journal of radiation oncology, biology, physics, .  show abstract

Lee, N.Y. Ferris, R.L. Psyrri, A. Haddad, R.I. Tahara, M. Bourhis, J. Harrington, K. Chang, P.M. Lin, J.-. Razaq, M.A. Teixeira, M.M. Lövey, J. Chamois, J. Rueda, A. Hu, C. Dunn, L.A. Dvorkin, M.V. De Beukelaer, S. Pavlov, D. Thurm, H. Cohen, E. (2021). Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial. The lancet oncology, Vol.22 (4), pp. 450-462.

Haas, L. Elewaut, A. Gerard, C.L. Umkehrer, C. Leiendecker, L. Pedersen, M. Krecioch, I. Hoffmann, D. Novatchkova, M. Kuttke, M. Neumann, T. da Silva, I.P. Witthock, H. Cuendet, M.A. Carotta, S. Harrington, K.J. Zuber, J. Scolyer, R.A. Long, G.V. Wilmott, J.S. Michielin, O. Vanharanta, S. Wiesner, T. Obenauf, A.C. (2021). Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma. Nature cancer, Vol.2 (7), pp. 693-708.

Vile, R.G. Melcher, A. Pandha, H. Harrington, K.J. Pulido, J.S. (2021). APOBEC and cancer viroimmunotherapy: Thinking the Unthinkable. Clinical cancer research : an official journal of the american association for cancer research, .  show abstract

Edmond, M. Nenclares, P. Harrington, K. Ap Dafydd, D. Bagwan, I. Begg, D. Lingley, K. Patterson, G. Payne, M. Steven, N. Turnbull, N. Yip, K. Silva, P. Kerawala, C. Paleri, V. King, E. (2021). What is the role of the surgeon in the management of head and neck mucosal melanoma in the immunotherapy era?. Head & neck, Vol.43 (11), pp. 3498-3503.

de Mol van Otterloo, S.R. Christodouleas, J.P. Blezer, E.L. Akhiat, H. Brown, K. Choudhury, A. Eggert, D. Erickson, B.A. Daamen, L.A. Faivre-Finn, C. Fuller, C.D. Goldwein, J. Hafeez, S. Hall, E. Harrington, K.J. van der Heide, U.A. Huddart, R.A. Intven, M.P. Kirby, A.M. Lalondrelle, S. McCann, C. Minsky, B.D. Mook, S. Nowee, M.E. Oelfke, U. Orrling, K. Philippens, M.E. Sahgal, A. Schultz, C.J. Tersteeg, R.J. Tijssen, R.H. Tree, A.C. van Triest, B. Tseng, C.-. Hall, W.A. Verkooijen, H.M. (2021). Patterns of Care, Tolerability, and Safety of the First Cohort of Patients Treated on a Novel High-Field MR-Linac Within the MOMENTUM Study: Initial Results From a Prospective Multi-Institutional Registry. International journal of radiation oncology*biology*physics, Vol.111 (4), pp. 867-875.

Bergamini, C. Ferris, R.L. Xie, J. Mariani, G. Ali, M. Holmes, W.C. Harrington, K. Psyrri, A. Cavalieri, S. Licitra, L. (2021). Bleeding complications in patients with squamous cell carcinoma of the head and neck. , Vol.43 (9), pp. 2844-2858.  show abstract

Appleton, E. Hassan, J. Chan Wah Hak, C. Sivamanoharan, N. Wilkins, A. Samson, A. Ono, M. Harrington, K.J. Melcher, A. Wennerberg, E. (2021). Kickstarting Immunity in Cold Tumours: Localised Tumour Therapy Combinations With Immune Checkpoint Blockade. , Vol.12, p. 754436.  show abstract

Vasiliadou, I. Breik, O. Baker, H. Leslie, I. Sim, V.R. Hegarty, G. Michaelidou, A. Nathan, K. Hartley, A. Good, J. Sanghera, P. Fong, C. Urbano, T.G. Lei, M. Petkar, I. Ferreira, M.R. Nutting, C. Wong, K.H. Newbold, K. Harrington, K. Bhide, S. Kong, A. (2021). Safety and Treatment Outcomes of Nivolumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Retrospective Multicenter Cohort Study. Cancers, Vol.13 (6).  show abstract

Gupta, A. Wong, K.H. Newbold, K. Bhide, S. Nutting, C. Harrington, K.J. (2021). Early-Stage Glottic Squamous Cell Carcinoma in the Era of Image-Guided Radiotherapy. , Vol.11, p. 753908.  show abstract

Ho, A.L. Brana, I. Haddad, R. Bauman, J. Bible, K. Oosting, S. Wong, D.J. Ahn, M.-. Boni, V. Even, C. Fayette, J. Flor, M.J. Harrington, K. Kim, S.-. Licitra, L. Nixon, I. Saba, N.F. Hackenberg, S. Specenier, P. Worden, F. Balsara, B. Leoni, M. Martell, B. Scholz, C. Gualberto, A. (2021). Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations. Journal of clinical oncology : official journal of the american society of clinical oncology, , pp. JCO2002903-?.  show abstract

Kottke, T. Tonne, J. Evgin, L. Driscoll, C.B. van Vloten, J. Jennings, V.A. Huff, A.L. Zell, B. Thompson, J.M. Wongthida, P. Pulido, J. Schuelke, M.R. Samson, A. Selby, P. Ilett, E. McNiven, M. Roberts, L.R. Borad, M.J. Pandha, H. Harrington, K. Melcher, A. Vile, R.G. (2021). Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy. Nature communications, Vol.12 (1), pp. 1930-?.  show abstract

Fendler, A. Shepherd, S.T. Au, L. Wilkinson, K.A. Wu, M. Byrne, F. Cerrone, M. Schmitt, A.M. Joharatnam-Hogan, N. Shum, B. Tippu, Z. Rzeniewicz, K. Boos, L.A. Harvey, R. Carlyle, E. Edmonds, K. Del Rosario, L. Sarker, S. Lingard, K. Mangwende, M. Holt, L. Ahmod, H. Korteweg, J. Foley, T. Bazin, J. Gordon, W. Barber, T. Emslie-Henry, A. Xie, W. Gerard, C.L. Deng, D. Wall, E.C. Agua-Doce, A. Namjou, S. Caidan, S. Gavrielides, M. MacRae, J. Kelly, G. Peat, K. Kelly, D. Murra, A. Kelly, K. O'Flaherty, M. Dowdie, L. Ash, N. Gronthoud, F. Shea, R.L. Gardner, G. Murray, D. Kinnaird, F. Cui, W. Pascual, J. Rodney, S. Mencel, J. Curtis, O. Stephenson, C. Robinson, A. Oza, B. Farag, S. Leslie, I. Rogiers, A. Iyengar, S. Ethell, M. Messiou, C. Cunningham, D. Chau, I. Starling, N. Turner, N. Welsh, L. van As, N. Jones, R.L. Droney, J. Banerjee, S. Tatham, K.C. O'Brien, M. Harrington, K. Bhide, S. Okines, A. Reid, A. Young, K. Furness, A.J. Pickering, L. Swanton, C. Gandhi, S. Gamblin, S. Bauer, D.L. Kassiotis, G. Kumar, S. Yousaf, N. Jhanji, S. Nicholson, E. Howell, M. Walker, S. Wilkinson, R.J. Larkin, J. Turajlic, S. (2021). Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study. Nature cancer, , pp. ?-? (31).

de Mol van Otterloo, S.R. Christodouleas, J.P. Blezer, E.L. Akhiat, H. Brown, K. Choudhury, A. Eggert, D. Erickson, B.A. Faivre-Finn, C. Fuller, C.D. Goldwein, J. Hafeez, S. Hall, E. Harrington, K.J. van der Heide, U.A. Huddart, R.A. Intven, M.P. Kirby, A.M. Lalondrelle, S. McCann, C. Minsky, B.D. Mook, S. Nowee, M.E. Oelfke, U. Orrling, K. Sahgal, A. Sarmiento, J.G. Schultz, C.J. Tersteeg, R.J. Tijssen, R.H. Tree, A.C. van Triest, B. Hall, W.A. Verkooijen, H.M. (2020). The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy. Frontiers in oncology, Vol.10, pp. 1328-?.  show abstract

Lee, J.Y. Cutts, R.J. White, I. Augustin, Y. Garcia-Murillas, I. Fenwick, K. Matthews, N. Turner, N.C. Harrington, K. Gilbert, D.C. Bhide, S. (2020). Next Generation Sequencing Assay for Detection of Circulating HPV DNA (cHPV-DNA) in Patients Undergoing Radical (Chemo)Radiotherapy in Anal Squamous Cell Carcinoma (ASCC). Frontiers in oncology, Vol.10, pp. 505-?.  show abstract

Arwert, E.N. Milford, E.L. Rullan, A. Derzsi, S. Hooper, S. Kato, T. Mansfield, D. Melcher, A. Harrington, K.J. Sahai, E. (2020). STING and IRF3 in stromal fibroblasts enable sensing of genomic stress in cancer cells to undermine oncolytic viral therapy. Nature cell biology, Vol.22 (7), pp. 758-766.

Gurney-Champion, O.J. Rauh, S.S. Harrington, K. Oelfke, U. Laun, F.B. Wetscherek, A. (2020). Optimal acquisition scheme for flow-compensated intravoxel incoherent motion diffusion-weighted imaging in the abdomen: An accurate and precise clinically feasible protocol. Magnetic resonance in medicine, Vol.83 (3), pp. 1003-1015.  show abstract

Grünwald, V. Chirovsky, D. Cheung, W.Y. Bertolini, F. Ahn, M.-. Yang, M.-. Castro, G. Berrocal, A. Sjoquist, K. Kuyas, H. Auclair, V. Guillaume, X. Joo, S. Shah, R. Harrington, K. GLANCE H&N STUDY Investigators, (2020). Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results of the GLANCE H&N study. Oral oncology, Vol.102, pp. 104526-?.  show abstract

McLaughlin, M. Pedersen, M. Roulstone, V. Bergerhoff, K.F. Smith, H.G. Whittock, H. Kyula, J.N. Dillon, M.T. Pandha, H.S. Vile, R. Melcher, A.A. Harrington, K.J. (2020). The PERK Inhibitor GSK2606414 Enhances Reovirus Infection in Head and Neck Squamous Cell Carcinoma via an ATF4-Dependent Mechanism. Molecular therapy oncolytics, Vol.16, pp. 238-249.  show abstract

Galluzzi, L. Vitale, I. Warren, S. Adjemian, S. Agostinis, P. Martinez, A.B. Chan, T.A. Coukos, G. Demaria, S. Deutsch, E. Draganov, D. Edelson, R.L. Formenti, S.C. Fucikova, J. Gabriele, L. Gaipl, U.S. Gameiro, S.R. Garg, A.D. Golden, E. Han, J. Harrington, K.J. Hemminki, A. Hodge, J.W. Hossain, D.M. Illidge, T. Karin, M. Kaufman, H.L. Kepp, O. Kroemer, G. Lasarte, J.J. Loi, S. Lotze, M.T. Manic, G. Merghoub, T. Melcher, A.A. Mossman, K.L. Prosper, F. Rekdal, Ø. Rescigno, M. Riganti, C. Sistigu, A. Smyth, M.J. Spisek, R. Stagg, J. Strauss, B.E. Tang, D. Tatsuno, K. van Gool, S.W. Vandenabeele, P. Yamazaki, T. Zamarin, D. Zitvogel, L. Cesano, A. Marincola, F.M. (2020). Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. Journal for immunotherapy of cancer, Vol.8 (1).  show abstract

Machiels, J.-. Tao, Y. Burtness, B. Tahara, M. Licitra, L. Rischin, D. Waldron, J. Simon, C. Gregoire, V. Harrington, K. Alves, G.V. Figueiredo Lima, I.P. Pointreau, Y. M Hughes, B.G. Aksoy, S. Hetnal, M. Ge, J.Y. Brown, H. Cheng, J. Bidadi, B. Siu, L.L. (2020). Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412. Future oncology (london, england), Vol.16 (18), pp. 1235-1243.  show abstract

McLaughlin, M. Patin, E.C. Pedersen, M. Wilkins, A. Dillon, M.T. Melcher, A.A. Harrington, K.J. (2020). Inflammatory microenvironment remodelling by tumour cells after radiotherapy. Nature reviews. cancer, Vol.20 (4), pp. 203-217.  show abstract

Haddad, R. Cohen, E.E. Venkatachalam, M. Young, K. Singh, P. Shaw, J.W. Korytowsky, B. Abraham, P. Harrington, K.J. (2020). Cost-effectiveness analysis of nivolumab for the treatment of squamous cell carcinoma of the head and neck in the United States. Journal of medical economics, Vol.23 (5), pp. 442-447.  show abstract

Chiu, M. Armstrong, E.J. Jennings, V. Foo, S. Crespo-Rodriguez, E. Bozhanova, G. Patin, E.C. McLaughlin, M. Mansfield, D. Baker, G. Grove, L. Pedersen, M. Kyula, J. Roulstone, V. Wilkins, A. McDonald, F. Harrington, K. Melcher, A. (2020). Combination therapy with oncolytic viruses and immune checkpoint inhibitors. Expert opinion on biological therapy, Vol.20 (6), pp. 635-652.  show abstract

Smith, H.G. Jamal, K. Dayal, J.H. Tenev, T. Kyula-Currie, J. Guppy, N. Gazinska, P. Roulstone, V. Liccardi, G. Davies, E. Roxanis, I. Melcher, A.A. Hayes, A.J. Inman, G.J. Harrington, K.J. Meier, P. (2020). RIPK1-mediated immunogenic cell death promotes anti-tumour immunity against soft-tissue sarcoma. Embo molecular medicine, Vol.12 (6), pp. e10979-?.  show abstract

Driscoll, C.B. Schuelke, M.R. Kottke, T. Thompson, J.M. Wongthida, P. Tonne, J.M. Huff, A.L. Miller, A. Shim, K.G. Molan, A. Wetmore, C. Selby, P. Samson, A. Harrington, K. Pandha, H. Melcher, A. Pulido, J.S. Harris, R. Evgin, L. Vile, R.G. (2020). APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy. Nature communications, Vol.11 (1), pp. 790-?.  show abstract

Gurney-Champion, O.J. Kieselmann, J.P. Wong, K.H. Ng-Cheng-Hin, B. Harrington, K. Oelfke, U. (2020). A convolutional neural network for contouring metastatic lymph nodes on diffusion-weighted magnetic resonance images for assessment of radiotherapy response. Physics and imaging in radiation oncology, Vol.15, pp. 1-7.  show abstract

Crespo-Rodriguez, E. Bergerhoff, K. Bozhanova, G. Foo, S. Patin, E.C. Whittock, H. Buus, R. Haider, S. Muirhead, G. Thway, K. Newbold, K. Coffin, R.S. Vile, R.G. Kim, D. McLaughlin, M. Melcher, A.A. Harrington, K.J. Pedersen, M. (2020). Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer. Journal for immunotherapy of cancer, Vol.8 (2).  show abstract

Angelis, V. Tippu, Z. Joshi, K. Reis, S. Gronthoud, F. Fribbens, C. Okines, A. Stanway, S. Cottier, E. McGrath, S. Watkins, D. Noble, J. Bhosle, J. Gerlinger, M. Hamid, I. Soliman, H. Nenclares, P. Jones, R. Harrington, K. Gennatas, S. (2020). Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancer. European journal of cancer (oxford, england : 1990), Vol.136, pp. 99-106.  show abstract

Snow, H. Hazell, S. Francis, N. Mohammed, K. O'Neill, S. Davies, E. Mansfield, D. Messiou, C. Hujairi, N. Nicol, D. Harrington, K. Smith, M. (2020). Prostate-specific membrane antigen expression in melanoma metastases. Journal of cutaneous pathology, Vol.47 (12), pp. 1115-1122.  show abstract

Harrington, K.J. Soulières, D. Le Tourneau, C. Dinis, J. Licitra, L.F. Ahn, M.-. Soria, A. Machiels, J.-. Mach, N. Mehra, R. Burtness, B. Ellison, M.C. Cheng, J.D. Chirovsky, D.R. Swaby, R.F. Cohen, E.E. (2020). Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040. Journal of the national cancer institute, Vol.113 (2), pp. 171-181.  show abstract

Kong, A. Good, J. Kirkham, A. Savage, J. Mant, R. Llewellyn, L. Parish, J. Spruce, R. Forster, M. Schipani, S. Harrington, K. Sacco, J. Murray, P. Middleton, G. Yap, C. Mehanna, H. (2020). Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: the WISTERIA trial protocol. Bmj open, Vol.10 (3), pp. e033009-?.  show abstract

Mączyńska, J. Da Pieve, C. Burley, T.A. Raes, F. Shah, A. Saczko, J. Harrington, K.J. Kramer-Marek, G. (2020). Immunomodulatory activity of IR700-labelled affibody targeting HER2. Cell death & disease, Vol.11 (10), pp. 886-?.  show abstract

Dillon, M.T. Grove, L. Newbold, K.L. Shaw, H. Brown, N.F. Mendell, J. Chen, S. Beckman, R.A. Jennings, A. Ricamara, M. Greenberg, J. Forster, M. Harrington, K.J. (2019). Patritumab with Cetuximab plus Platinum-Containing Therapy in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: An Open-Label, Phase Ib Study. Clinical cancer research : an official journal of the american association for cancer research, Vol.25 (2), pp. 487-495.  show abstract

Mehanna, H. Robinson, M. Hartley, A. Kong, A. Foran, B. Fulton-Lieuw, T. Dalby, M. Mistry, P. Sen, M. O'Toole, L. Al Booz, H. Dyker, K. Moleron, R. Whitaker, S. Brennan, S. Cook, A. Griffin, M. Aynsley, E. Rolles, M. De Winton, E. Chan, A. Srinivasan, D. Nixon, I. Grumett, J. Leemans, C.R. Buter, J. Henderson, J. Harrington, K. McConkey, C. Gray, A. Dunn, J. De-ESCALaTE HPV Trial Group, (2019). Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial. Lancet (london, england), Vol.393 (10166), pp. 51-60.  show abstract

Cohen, E.E. Soulières, D. Le Tourneau, C. Dinis, J. Licitra, L. Ahn, M.-. Soria, A. Machiels, J.-. Mach, N. Mehra, R. Burtness, B. Zhang, P. Cheng, J. Swaby, R.F. Harrington, K.J. KEYNOTE-040 investigators, (2019). Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study. Lancet (london, england), Vol.393 (10167), pp. 156-167.  show abstract

Burley, T.A. Da Pieve, C. Martins, C.D. Ciobota, D.M. Allott, L. Oyen, W.J. Harrington, K.J. Smith, G. Kramer-Marek, G. (2019). Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models. Journal of nuclear medicine : official publication, society of nuclear medicine, Vol.60 (3), pp. 353-361.  show abstract

Wilkins, A.C. Patin, E.C. Harrington, K.J. Melcher, A.A. (2019). The immunological consequences of radiation-induced DNA damage. The journal of pathology, Vol.247 (5), pp. 606-614.  show abstract

Evgin, L. Huff, A.L. Kottke, T. Thompson, J. Molan, A.M. Driscoll, C.B. Schuelke, M. Shim, K.G. Wongthida, P. Ilett, E.J. Smith, K.K. Harris, R.S. Coffey, M. Pulido, J.S. Pandha, H. Selby, P.J. Harrington, K.J. Melcher, A. Vile, R.G. (2019). Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line Treatment. Cancer immunology research, Vol.7 (5), pp. 828-840.  show abstract

Smith, H.G. Mansfield, D. Roulstone, V. Kyula-Currie, J.N. McLaughlin, M. Patel, R.R. Bergerhoff, K.F. Paget, J.T. Dillon, M.T. Khan, A. Melcher, A. Thway, K. Harrington, K.J. Hayes, A.J. (2019). PD-1 Blockade Following Isolated Limb Perfusion with Vaccinia Virus Prevents Local and Distant Relapse of Soft-tissue Sarcoma. Clinical cancer research : an official journal of the american association for cancer research, Vol.25 (11), pp. 3443-3454.  show abstract

Wilkins, A. McDonald, F. Harrington, K. Melcher, A. (2019). Radiotherapy enhances responses of lung cancer to CTLA-4 blockade. Journal for immunotherapy of cancer, Vol.7 (1), pp. 64-?.  show abstract

Jennings, V.A. Scott, G.B. Rose, A.M. Scott, K.J. Migneco, G. Keller, B. Reilly, K. Donnelly, O. Peach, H. Dewar, D. Harrington, K.J. Pandha, H. Samson, A. Vile, R.G. Melcher, A.A. Errington-Mais, F. (2019). Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase Inhibition. Molecular therapy : the journal of the american society of gene therapy, Vol.27 (6), pp. 1139-1152.  show abstract

Andtbacka, R.H. Collichio, F. Harrington, K.J. Middleton, M.R. Downey, G. Ӧhrling, K. Kaufman, H.L. (2019). Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III-IV melanoma. Journal for immunotherapy of cancer, Vol.7 (1), pp. 145-?.  show abstract

Dillon, M.T. Bergerhoff, K.F. Pedersen, M. Whittock, H. Crespo-Rodriguez, E. Patin, E.C. Pearson, A. Smith, H.G. Paget, J.T. Patel, R.R. Foo, S. Bozhanova, G. Ragulan, C. Fontana, E. Desai, K. Wilkins, A.C. Sadanandam, A. Melcher, A. McLaughlin, M. Harrington, K.J. (2019). ATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor Microenvironment. Clinical cancer research : an official journal of the american association for cancer research, Vol.25 (11), pp. 3392-3403.  show abstract

Müller, L.M. Holmes, M. Michael, J.L. Scott, G.B. West, E.J. Scott, K.J. Parrish, C. Hall, K. Stäble, S. Jennings, V.A. Cullen, M. McConnell, S. Langton, C. Tidswell, E.L. Shafren, D. Samson, A. Harrington, K.J. Pandha, H. Ralph, C. Kelly, R.J. Cook, G. Melcher, A.A. Errington-Mais, F. (2019). Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21. Journal for immunotherapy of cancer, Vol.7 (1), pp. 164-?.  show abstract

Saba, N.F. Blumenschein, G. Guigay, J. Licitra, L. Fayette, J. Harrington, K.J. Kiyota, N. Gillison, M.L. Ferris, R.L. Jayaprakash, V. Li, L. Brossart, P. (2019). Nivolumab versus investigator's choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by age. Oral oncology, Vol.96, pp. 7-14.  show abstract

Ferris, R.L. Licitra, L. Fayette, J. Even, C. Blumenschein, G. Harrington, K.J. Guigay, J. Vokes, E.E. Saba, N.F. Haddad, R. Ramkumar, S. Russell, J. Brossart, P. Tahara, M. Colevas, A.D. Concha-Benavente, F. Lynch, M. Li, L. Gillison, M.L. (2019). Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use. Clinical cancer research : an official journal of the american association for cancer research, Vol.25 (17), pp. 5221-5230.  show abstract

Haddad, R. Concha-Benavente, F. Blumenschein, G. Fayette, J. Guigay, J. Colevas, A.D. Licitra, L. Kasper, S. Vokes, E.E. Worden, F. Saba, N.F. Tahara, M. Jayaprakash, V. Lynch, M. Li, L. Gillison, M.L. Harrington, K.J. Ferris, R.L. (2019). Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial. Cancer, Vol.125 (18), pp. 3208-3218.  show abstract

Thomas, S. Kuncheria, L. Roulstone, V. Kyula, J.N. Mansfield, D. Bommareddy, P.K. Smith, H. Kaufman, H.L. Harrington, K.J. Coffin, R.S. (2019). Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1. Journal for immunotherapy of cancer, Vol.7 (1), pp. 214-?.  show abstract

Annels, N.E. Mansfield, D. Arif, M. Ballesteros-Merino, C. Simpson, G.R. Denyer, M. Sandhu, S.S. Melcher, A.A. Harrington, K.J. Davies, B. Au, G. Grose, M. Bagwan, I. Fox, B. Vile, R. Mostafid, H. Shafren, D. Pandha, H.S. (2019). Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer. Clinical cancer research : an official journal of the american association for cancer research, Vol.25 (19), pp. 5818-5831.  show abstract

Forster, M.D. Dillon, M.T. Kocsis, J. Remenár, É. Pajkos, G. Rolland, F. Greenberg, J. Harrington, K.J. (2019). Patritumab or placebo, with cetuximab plus platinum therapy in recurrent or metastatic squamous cell carcinoma of the head and neck: A randomised phase II study. European journal of cancer (oxford, england : 1990), Vol.123, pp. 36-47.  show abstract

Burtness, B. Haddad, R. Dinis, J. Trigo, J. Yokota, T. de Souza Viana, L. Romanov, I. Vermorken, J. Bourhis, J. Tahara, M. Martins Segalla, J.G. Psyrri, A. Vasilevskaya, I. Nangia, C.S. Chaves-Conde, M. Kiyota, N. Homma, A. Holeckova, P. Del Campo, J.M. Asarawala, N. Nicolau, U.R. Rauch, D. Even, C. Wang, B. Gibson, N. Ehrnrooth, E. Harrington, K. Cohen, E.E. LUX-Head & Neck 2 investigators, (2019). Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial. Jama oncology, .  show abstract

Gurney-Champion, O.J. Collins, D.J. Wetscherek, A. Rata, M. Klaassen, R. van Laarhoven, H.W. Harrington, K.J. Oelfke, U. Orton, M.R. (2019). Principal component analysis fosr fast and model-free denoising of multi b-value diffusion-weighted MR images. Physics in medicine and biology, Vol.64 (10), pp. 105015-?.  show abstract

Lee, A.W. Ng, W.T. Pan, J.J. Poh, S.S. Ahn, Y.C. AlHussain, H. Corry, J. Grau, C. Grégoire, V. Harrington, K.J. Hu, C.S. Kwong, D.L. Langendijk, J.A. Le, Q.T. Lee, N.Y. Lin, J.C. Lu, T.X. Mendenhall, W.M. O'Sullivan, B. Ozyar, E. Peters, L.J. Rosenthal, D.I. Soong, Y.L. Tao, Y. Yom, S.S. Wee, J.T. (2018). International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma. Radiotherapy and oncology : journal of the european society for therapeutic radiology and oncology, Vol.126 (1), pp. 25-36.  show abstract

Samson, A. Scott, K.J. Taggart, D. West, E.J. Wilson, E. Nuovo, G.J. Thomson, S. Corns, R. Mathew, R.K. Fuller, M.J. Kottke, T.J. Thompson, J.M. Ilett, E.J. Cockle, J.V. van Hille, P. Sivakumar, G. Polson, E.S. Turnbull, S.J. Appleton, E.S. Migneco, G. Rose, A.S. Coffey, M.C. Beirne, D.A. Collinson, F.J. Ralph, C. Alan Anthoney, D. Twelves, C.J. Furness, A.J. Quezada, S.A. Wurdak, H. Errington-Mais, F. Pandha, H. Harrington, K.J. Selby, P.J. Vile, R.G. Griffin, S.D. Stead, L.F. Short, S.C. Melcher, A.A. (2018). Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade. Science translational medicine, Vol.10 (422).  show abstract

Dean, J. Wong, K. Gay, H. Welsh, L. Jones, A.-. Schick, U. Oh, J.H. Apte, A. Newbold, K. Bhide, S. Harrington, K. Deasy, J. Nutting, C. Gulliford, S. (2018). Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy. Clinical and translational radiation oncology, Vol.8, pp. 27-39.  show abstract

Hafsi, H. Dillon, M.T. Barker, H.E. Kyula, J.N. Schick, U. Paget, J.T. Smith, H.G. Pedersen, M. McLaughlin, M. Harrington, K.J. (2018). Combined ATR and DNA-PK Inhibition Radiosensitizes Tumor Cells Independently of Their p53 Status. Frontiers in oncology, Vol.8, pp. 245-?.  show abstract

Khan, A.A. Paget, J.T. McLaughlin, M. Kyula, J.N. Wilkinson, M.J. Pencavel, T. Mansfield, D. Roulstone, V. Seth, R. Halle, M. Somaiah, N. Boult, J.K. Robinson, S.P. Pandha, H.S. Vile, R.G. Melcher, A.A. Harris, P.A. Harrington, K.J. (2018). Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissues. Science translational medicine, Vol.10 (425).  show abstract

Heatley, N. Harrington, K.J. Thway, K. (2018). Warthin Tumor-Like Mucoepidermoid Carcinoma. International journal of surgical pathology, Vol.26 (1), pp. 31-33.  show abstract

Gurney-Champion, O.J. McQuaid, D. Dunlop, A. Wong, K.H. Welsh, L.C. Riddell, A.M. Koh, D.-. Oelfke, U. Leach, M.O. Nutting, C.M. Bhide, S.A. Harrington, K.J. Panek, R. Newbold, K.L. (2018). MRI-based Assessment of 3D Intrafractional Motion of Head and Neck Cancer for Radiation Therapy. International journal of radiation oncology, biology, physics, Vol.100 (2), pp. 306-316.  show abstract

Samson, A. Bentham, M.J. Scott, K. Nuovo, G. Bloy, A. Appleton, E. Adair, R.A. Dave, R. Peckham-Cooper, A. Toogood, G. Nagamori, S. Coffey, M. Vile, R. Harrington, K. Selby, P. Errington-Mais, F. Melcher, A. Griffin, S. (2018). Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer. Gut, Vol.67 (3), pp. 562-573.  show abstract

Yip, K. Melcher, A. Harrington, K. Illidge, T. Nobes, J. Webster, A. Smith, D. Lorigan, P. Nathan, P. Larkin, J. (2018). Pembrolizumab in Combination with Radiotherapy for Metastatic Melanoma - Introducing the PERM Trial. Clinical oncology (royal college of radiologists (great britain)), Vol.30 (4), pp. 201-203.

Martins, C.D. Da Pieve, C. Burley, T.A. Smith, R. Ciobota, D.M. Allott, L. Harrington, K.J. Oyen, W.J. Smith, G. Kramer-Marek, G. (2018). HER3-Mediated Resistance to Hsp90 Inhibition Detected in Breast Cancer Xenografts by Affibody-Based PET Imaging. Clinical cancer research : an official journal of the american association for cancer research, Vol.24 (8), pp. 1853-1865.  show abstract

Rooney, K.P. Miah, A.B. Bhide, S.A. Guerrero-Urbano, M.T. Sharabiani, M.T. Newbold, K.L. Grove, L. Harrington, K.J. Nutting, C.M. (2018). Intensity modulated radiotherapy in locally advanced thyroid cancer: Outcomes of a sequential phase I dose-escalation study. Radiotherapy and oncology : journal of the european society for therapeutic radiology and oncology, Vol.127 (1), pp. 43-48.  show abstract

Wong, K.H. Panek, R. Dunlop, A. Mcquaid, D. Riddell, A. Welsh, L.C. Murray, I. Koh, D.-. Leach, M.O. Bhide, S.A. Nutting, C.M. Oyen, W.J. Harrington, K.J. Newbold, K.L. (2018). Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer. European journal of nuclear medicine and molecular imaging, Vol.45 (5), pp. 759-767.  show abstract

Petkar, I. Bhide, S. Newbold, K. Harrington, K. Nutting, C. (2018). Practice patterns for the radical treatment of nasopharyngeal cancer by head and neck oncologists in the United Kingdom. The british journal of radiology, Vol.91 (1085), pp. 20170590-?.  show abstract

Henderson, D.R. Tree, A.C. Harrington, K.J. van As, N.J. (2018). Dosimetric Implications of Computerised Tomography-Only versus Magnetic Resonance-Fusion Contouring in Stereotactic Body Radiotherapy for Prostate Cancer. Medicines (basel, switzerland), Vol.5 (2).  show abstract

Burley, T.A. Mączyńska, J. Shah, A. Szopa, W. Harrington, K.J. Boult, J.K. Mrozek-Wilczkiewicz, A. Vinci, M. Bamber, J.C. Kaspera, W. Kramer-Marek, G. (2018). Near-infrared photoimmunotherapy targeting EGFR-Shedding new light on glioblastoma treatment. International journal of cancer, Vol.142 (11), pp. 2363-2374.  show abstract

Comins, C. Simpson, G.R. Rogers, W. Relph, K. Harrington, K. Melcher, A. Roulstone, V. Kyula, J. Pandha, H. (2018). Synergistic antitumour effects of rapamycin and oncolytic reovirus. Cancer gene therapy, Vol.25 (5-6), pp. 148-160.  show abstract

Grønhøj, C. Jensen, D.H. Dehlendorff, C. Marklund, L. Wagner, S. Mehanna, H. Munck-Wikland, E. Ramqvist, T. Näsman, A. Wittekindt, C. Würdemann, N. Sharma, S.J. Gattenlöhner, S. Kiss, K. Andersen, E. Spruce, R. Batis, N. Robinson, M. Harrington, K. Winter, S. Jones, T.M. Klussmann, J.P. Dalianis, T. Friborg, J. von Buchwald, C. (2018). Development and external validation of nomograms in oropharyngeal cancer patients with known HPV-DNA status: a European Multicentre Study (OroGrams). British journal of cancer, Vol.118 (12), pp. 1672-1681.  show abstract

Ferris, R.L. Blumenschein, G. Fayette, J. Guigay, J. Colevas, A.D. Licitra, L. Harrington, K.J. Kasper, S. Vokes, E.E. Even, C. Worden, F. Saba, N.F. Docampo, L.C. Haddad, R. Rordorf, T. Kiyota, N. Tahara, M. Lynch, M. Jayaprakash, V. Li, L. Gillison, M.L. (2018). Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression. Oral oncology, Vol.81, pp. 45-51.  show abstract

Annels, N.E. Arif, M. Simpson, G.R. Denyer, M. Moller-Levet, C. Mansfield, D. Butler, R. Shafren, D. Au, G. Knowles, M. Harrington, K. Vile, R. Melcher, A. Pandha, H. (2018). Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus. Molecular therapy oncolytics, Vol.9, pp. 1-12.  show abstract

Agaimy, A. Fonseca, I. Martins, C. Thway, K. Barrette, R. Harrington, K.J. Hartmann, A. French, C.A. Fisher, C. (2018). NUT Carcinoma of the Salivary Glands: Clinicopathologic and Molecular Analysis of 3 Cases and a Survey of NUT Expression in Salivary Gland Carcinomas. The american journal of surgical pathology, Vol.42 (7), pp. 877-884.  show abstract

Tree, A.C. Jones, K. Hafeez, S. Sharabiani, M.T. Harrington, K.J. Lalondrelle, S. Ahmed, M. Huddart, R.A. (2018). Dose-limiting Urinary Toxicity With Pembrolizumab Combined With Weekly Hypofractionated Radiation Therapy in Bladder Cancer. International journal of radiation oncology, biology, physics, Vol.101 (5), pp. 1168-1171.  show abstract

Dillon, M.T. Boylan, Z. Smith, D. Guevara, J. Mohammed, K. Peckitt, C. Saunders, M. Banerji, U. Clack, G. Smith, S.A. Spicer, J.F. Forster, M.D. Harrington, K.J. (2018). PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours. Clinical and translational radiation oncology, Vol.12, pp. 16-20.  show abstract

Henderson, D.R. Murray, J.R. Gulliford, S.L. Tree, A.C. Harrington, K.J. Van As, N.J. (2018). An Investigation of Dosimetric Correlates of Acute Toxicity in Prostate Stereotactic Body Radiotherapy: Dose to Urinary Trigone is Associated with Acute Urinary Toxicity. Clinical oncology (royal college of radiologists (great britain)), Vol.30 (9), pp. 539-547.  show abstract

Gillison, M.L. Blumenschein, G. Fayette, J. Guigay, J. Colevas, A.D. Licitra, L. Harrington, K.J. Kasper, S. Vokes, E.E. Even, C. Worden, F. Saba, N.F. Iglesias Docampo, L.C. Haddad, R. Rordorf, T. Kiyota, N. Tahara, M. Monga, M. Lynch, M. Li, L. Ferris, R.L. (2018). CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer. The oncologist, Vol.23 (9), pp. 1079-1082.  show abstract

Tykodi, S.S. Schadendorf, D. Cella, D. Reck, M. Harrington, K. Wagner, S. Shaw, J.W. (2018). Patient-reported outcomes with nivolumab in advanced solid cancers. Cancer treatment reviews, Vol.70, pp. 75-87.  show abstract

Allin, D.M. Shaikh, R. Carter, P. Thway, K. Sharabiani, M.T. Gonzales-de-Castro, D. O'Leary, B. Garcia-Murillas, I. Bhide, S. Hubank, M. Harrington, K. Kim, D. Newbold, K. (2018). Circulating tumour DNA is a potential biomarker for disease progression and response to targeted therapy in advanced thyroid cancer. European journal of cancer (oxford, england : 1990), Vol.103, pp. 165-175.  show abstract

Nutting, C.M. Morden, J.P. Beasley, M. Bhide, S. Cook, A. De Winton, E. Emson, M. Evans, M. Fresco, L. Gollins, S. Gujral, D. Harrington, K. Joseph, M. Lemon, C. Luxon, L. van den Blink, Q. Mendes, R. Miah, A. Newbold, K. Prestwich, R. Robinson, M. Sanghera, P. Simpson, J. Sivaramalingam, M. Srihari, N.N. Sydenham, M. Wells, E. Witts, S. Hall, E. COSTAR Investigators, (2018). Results of a multicentre randomised controlled trial of cochlear-sparing intensity-modulated radiotherapy versus conventional radiotherapy in patients with parotid cancer (COSTAR; CRUK/08/004). European journal of cancer (oxford, england : 1990), Vol.103, pp. 249-258.  show abstract

Marabelle, A. Andtbacka, R. Harrington, K. Melero, I. Leidner, R. de Baere, T. Robert, C. Ascierto, P.A. Baurain, J.-. Imperiale, M. Rahimian, S. Tersago, D. Klumper, E. Hendriks, M. Kumar, R. Stern, M. Öhrling, K. Massacesi, C. Tchakov, I. Tse, A. Douillard, J.-. Tabernero, J. Haanen, J. Brody, J. (2018). Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT). Annals of oncology : official journal of the european society for medical oncology, Vol.29 (11), pp. 2163-2174.  show abstract

Bahig, H. Yuan, Y. Mohamed, A.S. Brock, K.K. Ng, S.P. Wang, J. Ding, Y. Hutcheson, K. McCulloch, M. Balter, P.A. Lai, S.Y. Al-Mamgani, A. Sonke, J.-. van der Heide, U.A. Nutting, C. Li, X.A. Robbins, J. Awan, M. Karam, I. Newbold, K. Harrington, K. Oelfke, U. Bhide, S. Philippens, M.E. Terhaard, C.H. McPartlin, A.J. Blanchard, P. Garden, A.S. Rosenthal, D.I. Gunn, G.B. Phan, J. Cazoulat, G. Aristophanous, M. McSpadden, K.K. Garcia, J.A. van den Berg, C.A. Raaijmakers, C.P. Kerkmeijer, L. Doornaert, P. Blinde, S. Frank, S.J. Fuller, C.D. (2018). Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial. Clinical and translational radiation oncology, Vol.13, pp. 19-23.  show abstract

Huff, A.L. Wongthida, P. Kottke, T. Thompson, J.M. Driscoll, C.B. Schuelke, M. Shim, K.G. Harris, R.S. Molan, A. Pulido, J.S. Selby, P.J. Harrington, K.J. Melcher, A. Evgin, L. Vile, R.G. (2018). APOBEC3 Mediates Resistance to Oncolytic Viral Therapy. Molecular therapy oncolytics, Vol.11, pp. 1-13.  show abstract

Gujral, D.M. Long, M. Roe, J.W. Harrington, K.J. Nutting, C.M. (2017). Standardisation of Target Volume Delineation for Carotid-sparing Intensity-modulated Radiotherapy in Early Glottis Cancer. Clinical oncology (royal college of radiologists (great britain)), Vol.29 (1), pp. 42-50.  show abstract

Welsh, L. Panek, R. Riddell, A. Wong, K. Leach, M.O. Tavassoli, M. Rahman, D. Schmidt, M. Hurley, T. Grove, L. Richards, T. Koh, D.-. Nutting, C. Harrington, K. Newbold, K. Bhide, S. (2017). Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck. British journal of cancer, Vol.116 (1), pp. 28-35.  show abstract

Dillon, M.T. Barker, H.E. Pedersen, M. Hafsi, H. Bhide, S.A. Newbold, K.L. Nutting, C.M. McLaughlin, M. Harrington, K.J. (2017). Radiosensitization by the ATR Inhibitor AZD6738 through Generation of Acentric Micronuclei. Molecular cancer therapeutics, Vol.16 (1), pp. 25-34.  show abstract

Harrington, K.J. Michielin, O. Malvehy, J. Pezzani Grüter, I. Grove, L. Frauchiger, A.L. Dummer, R. (2017). A practical guide to the handling and administration of talimogene laherparepvec in Europe. Oncotargets and therapy, Vol.10, pp. 3867-3880.  show abstract

Ilett, E. Kottke, T. Thompson, J. Rajani, K. Zaidi, S. Evgin, L. Coffey, M. Ralph, C. Diaz, R. Pandha, H. Harrington, K. Selby, P. Bram, R. Melcher, A. Vile, R. (2017). Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy. Gene therapy, Vol.24 (1), pp. 21-30.  show abstract

Wong, K.H. Kuciejewska, A. Sharabiani, M.T. Ng-Cheng-Hin, B. Hoy, S. Hurley, T. Rydon, J. Grove, L. Santos, A. Ryugenji, M. Bhide, S.A. Nutting, C.M. Harrington, K.J. Newbold, K.L. (2017). A randomised controlled trial of Caphosol mouthwash in management of radiation-induced mucositis in head and neck cancer. Radiotherapy and oncology : journal of the european society for therapeutic radiology and oncology, Vol.122 (2), pp. 207-211.  show abstract

Patel, R. Barker, H.E. Kyula, J. McLaughlin, M. Dillon, M.T. Schick, U. Hafsi, H. Thompson, A. Khoo, V. Harrington, K. Zaidi, S. (2017). An orally bioavailable Chk1 inhibitor, CCT244747, sensitizes bladder and head and neck cancer cell lines to radiation. Radiotherapy and oncology : journal of the european society for therapeutic radiology and oncology, Vol.122 (3), pp. 470-475.  show abstract

Guerreiro, F. Burgos, N. Dunlop, A. Wong, K. Petkar, I. Nutting, C. Harrington, K. Bhide, S. Newbold, K. Dearnaley, D. deSouza, N.M. Morgan, V.A. McClelland, J. Nill, S. Cardoso, M.J. Ourselin, S. Oelfke, U. Knopf, A.C. (2017). Evaluation of a multi-atlas CT synthesis approach for MRI-only radiotherapy treatment planning. Physica medica : pm : an international journal devoted to the applications of physics to medicine and biology : official journal of the italian association of biomedical physics (aifb), Vol.35, pp. 7-17.  show abstract

Wong, K.H. Panek, R. Bhide, S.A. Nutting, C.M. Harrington, K.J. Newbold, K.L. (2017). The emerging potential of magnetic resonance imaging in personalizing radiotherapy for head and neck cancer: an oncologist's perspective. The british journal of radiology, Vol.90 (1071), pp. 20160768-?.  show abstract

Sundar, R. Valeri, N. Harrington, K.J. Yap, T.A. (2017). Combining Molecularly Targeted Agents: Is More Always Better?. Clinical cancer research : an official journal of the american association for cancer research, Vol.23 (5), pp. 1123-1125.  show abstract

Dean, J.A. Welsh, L.C. Wong, K.H. Aleksic, A. Dunne, E. Islam, M.R. Patel, A. Patel, P. Petkar, I. Phillips, I. Sham, J. Schick, U. Newbold, K.L. Bhide, S.A. Harrington, K.J. Nutting, C.M. Gulliford, S.L. (2017). Normal Tissue Complication Probability (NTCP) Modelling of Severe Acute Mucositis using a Novel Oral Mucosal Surface Organ at Risk. Clinical oncology (royal college of radiologists (great britain)), Vol.29 (4), pp. 263-273.  show abstract

Morgan, R. El-Tanani, M. Hunter, K.D. Harrington, K.J. Pandha, H.S. (2017). Targeting HOX/PBX dimers in cancer. Oncotarget, Vol.8 (19), pp. 32322-32331.  show abstract

Petkar, I. Bhide, S. Newbold, K. Harrington, K. Nutting, C. (2017). Dysphagia-optimised Intensity-modulated Radiotherapy Techniques in Pharyngeal Cancers: Is Anyone Going to Swallow it?. Clinical oncology (royal college of radiologists (great britain)), Vol.29 (7), pp. e110-e118.  show abstract

Panek, R. Welsh, L. Baker, L.C. Schmidt, M.A. Wong, K.H. Riddell, A.M. Koh, D.-. Dunlop, A. Mcquaid, D. d'Arcy, J.A. Bhide, S.A. Harrington, K.J. Nutting, C.M. Hopkinson, G. Richardson, C. Box, C. Eccles, S.A. Leach, M.O. Robinson, S.P. Newbold, K.L. (2017). Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRI. Clinical cancer research : an official journal of the american association for cancer research, Vol.23 (15), pp. 4233-4241.  show abstract

Harrington, K.J. Ferris, R.L. Blumenschein, G. Colevas, A.D. Fayette, J. Licitra, L. Kasper, S. Even, C. Vokes, E.E. Worden, F. Saba, N.F. Kiyota, N. Haddad, R. Tahara, M. Grünwald, V. Shaw, J.W. Monga, M. Lynch, M. Taylor, F. DeRosa, M. Morrissey, L. Cocks, K. Gillison, M.L. Guigay, J. (2017). Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial. The lancet. oncology, Vol.18 (8), pp. 1104-1115.  show abstract

Lee, J.Y. Garcia-Murillas, I. Cutts, R.J. De Castro, D.G. Grove, L. Hurley, T. Wang, F. Nutting, C. Newbold, K. Harrington, K. Turner, N. Bhide, S. (2017). Predicting response to radical (chemo)radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma. British journal of cancer, Vol.117 (6), pp. 876-883.  show abstract

Alharbi, R.A. Pandha, H.S. Simpson, G.R. Pettengell, R. Poterlowicz, K. Thompson, A. Harrington, K. El-Tanani, M. Morgan, R. (2017). Inhibition of HOX/PBX dimer formation leads to necroptosis in acute myeloid leukemia cells. Oncotarget, Vol.8 (52), pp. 89566-89579.  show abstract

Richards, T.M. Hurley, T. Grove, L. Harrington, K.J. Carpenter, G.H. Proctor, G.B. Nutting, C.M. (2017). The effect of parotid gland-sparing intensity-modulated radiotherapy on salivary composition, flow rate and xerostomia measures. Oral diseases, Vol.23 (7), pp. 990-1000.  show abstract

Harrington, K. Hall, E. Hawkins, M. Henry, A. MacKay, R. Maughan, T. McDonald, A. Nutting, C. Oelfke, U. Sebag-Montefiore, D. Sharma, R.A. van Herk, M. Faivre-Finn, C. ART-NET Steering Committee, (2017). Introducing the Cancer Research UK Advanced Radiotherapy Technologies Network (ART-NET). Clinical oncology (royal college of radiologists (great britain)), Vol.29 (11), pp. 707-710.

Kottke, T. Evgin, L. Shim, K.G. Rommelfanger, D. Boisgerault, N. Zaidi, S. Diaz, R.M. Thompson, J. Ilett, E. Coffey, M. Selby, P. Pandha, H. Harrington, K. Melcher, A. Vile, R. (2017). Subversion of NK-cell and TNFα Immune Surveillance Drives Tumor Recurrence. Cancer immunology research, Vol.5 (11), pp. 1029-1045.  show abstract

McLaughlin, M. Barker, H.E. Khan, A.A. Pedersen, M. Dillon, M. Mansfield, D.C. Patel, R. Kyula, J.N. Bhide, S.A. Newbold, K.L. Nutting, C.M. Harrington, K.J. (2017). HSP90 inhibition sensitizes head and neck cancer to platin-based chemoradiotherapy by modulation of the DNA damage response resulting in chromosomal fragmentation. Bmc cancer, Vol.17 (1), pp. 86-?.  show abstract

Harrington, K.J. Andtbacka, R.H. Collichio, F. Downey, G. Chen, L. Szabo, Z. Kaufman, H.L. (2016). Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVM1a melanoma: subanalysis of the Phase III OPTiM trial. Oncotargets and therapy, Vol.9, pp. 7081-7093.  show abstract

Gujral, D.M. Shah, B.N. Bhattacharyya, S. Senior, R. Harrington, K.J. Nutting, C.M. (2016). Contrast-enhanced ultrasound to assess plaque neovascularization in irradiated carotid arteries. International journal of cardiology, Vol.202, pp. 3-4.

Kottke, T. Shim, K.G. Alonso-Camino, V. Zaidi, S. Maria Diaz, R. Pulido, J. Thompson, J. Rajani, K.R. Evgin, L. Ilett, E. Pandha, H. Harrington, K. Selby, P. Melcher, A. Vile, R. (2016). Immunogenicity of self tumor associated proteins is enhanced through protein truncation. Molecular therapy oncolytics, Vol.3, pp. 16030-?.  show abstract

Kerkmeijer, L.G. Fuller, C.D. Verkooijen, H.M. Verheij, M. Choudhury, A. Harrington, K.J. Schultz, C. Sahgal, A. Frank, S.J. Goldwein, J. Brown, K.J. Minsky, B.D. van Vulpen, M. MR-Linac Consortium Clinical Steering Committee, (2016). The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development. Frontiers in oncology, Vol.6, pp. 215-?.  show abstract

Rajani, K. Parrish, C. Kottke, T. Thompson, J. Zaidi, S. Ilett, L. Shim, K.G. Diaz, R.-. Pandha, H. Harrington, K. Coffey, M. Melcher, A. Vile, R. (2016). Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses. Molecular therapy : the journal of the american society of gene therapy, Vol.24 (1), pp. 166-174.  show abstract

Sacco, J.J. Evans, M. Harrington, K.J. Man, S. Powell, N. Shaw, R.J. Jones, T.M. (2016). Systemic listeriosis following vaccination with the attenuated Listeria monocytogenes therapeutic vaccine, ADXS11-001. Human vaccines & immunotherapeutics, Vol.12 (4), pp. 1085-1086.

Gujral, D.M. Shah, B.N. Chahal, N.S. Bhattacharyya, S. Hooper, J. Senior, R. Harrington, K.J. Nutting, C.M. (2016). Carotid intima-medial thickness as a marker of radiation-induced carotid atherosclerosis. Radiotherapy and oncology, Vol.118 (2), pp. 323-329.

Gujral, D.M. Shah, B.N. Chahal, N.S. Bhattacharyya, S. Senior, R. Harrington, K.J. Nutting, C.M. (2016). Arterial Stiffness as a Biomarker of Radiation-Induced Carotid Atherosclerosis. Angiology, Vol.67 (3), pp. 266-271.  show abstract

Roe, J.W. Carding, P.N. Drinnan, M.J. Harrington, K.J. Nutting, C.M. (2016). Swallowing performance and tube feeding status in patients treated with parotid-sparing intensity-modulated radiotherapy for head and neck cancer. Head & neck, Vol.38 (S1), pp. E1436-E1444.

Dean, J.A. Welsh, L.C. McQuaid, D. Wong, K.H. Aleksic, A. Dunne, E. Islam, M.R. Patel, A. Patel, P. Petkar, I. Phillips, I. Sham, J. Newbold, K.L. Bhide, S.A. Harrington, K.J. Gulliford, S.L. Nutting, C.M. (2016). Assessment of fully-automated atlas-based segmentation of novel oral mucosal surface organ-at-risk. Radiotherapy and oncology : journal of the european society for therapeutic radiology and oncology, Vol.119 (1), pp. 166-171.  show abstract

Mansfield, D.C. Kyula, J.N. Rosenfelder, N. Chao-Chu, J. Kramer-Marek, G. Khan, A.A. Roulstone, V. McLaughlin, M. Melcher, A.A. Vile, R.G. Pandha, H.S. Khoo, V. Harrington, K.J. (2016). Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer. Gene therapy, Vol.23 (4), pp. 357-368.  show abstract

Mehanna, H. Franklin, N. Compton, N. Robinson, M. Powell, N. Biswas-Baldwin, N. Paleri, V. Hartley, A. Fresco, L. Al-Booz, H. Junor, E. El-Hariry, I. Roberts, S. Harrington, K. Ang, K.K. Dunn, J. Woodman, C. (2016). Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trials. Head & neck, Vol.38 (S1), pp. E1863-E1869.

Dwivedi, R.C. St Rose, S. Chisholm, E.J. Clarke, P.M. Kerawala, C.J. Nutting, C.M. Rhys-Evans, P.H. Kazi, R. Harrington, K.J. (2016). Acoustic parameters of speech: Lack of correlation with perceptual and questionnaire-based speech evaluation in patients with oral and oropharyngeal cancer treated with primary surgery. Head neck, Vol.38 (5), pp. 670-676.  show abstract

Jones, T.M. De, M. Foran, B. Harrington, K. Mortimore, S. (2016). Laryngeal cancer: United Kingdom National Multidisciplinary guidelines. The journal of laryngology and otology, Vol.130 (S2), pp. S75-S82.  show abstract

Shah, B.N. Gujral, D.M. Chahal, N.S. Harrington, K.J. Nutting, C.M. Senior, R. (2016). Plaque Neovascularization Is Increased in Human Carotid Atherosclerosis Related to Prior Neck Radiotherapy A Contrast-Enhanced Ultrasound Study. Jacc-cardiovascular imaging, Vol.9 (6), pp. 668-675.

Petkar, I. Rooney, K. Roe, J.W. Patterson, J.M. Bernstein, D. Tyler, J.M. Emson, M.A. Morden, J.P. Mertens, K. Miles, E. Beasley, M. Roques, T. Bhide, S.A. Newbold, K.L. Harrington, K.J. Hall, E. Nutting, C.M. (2016). DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer. Bmc cancer, Vol.16 (1), pp. 770-?.  show abstract

Gujral, D.M. Shah, B.N. Chahal, N.S. Bhattacharyya, S. Senior, R. Harrington, K.J. Nutting, C.M. (2016). Do traditional risk stratification models for cerebrovascular events apply in irradiated head and neck cancer patients?. Qjm : monthly journal of the association of physicians, Vol.109 (6), pp. 383-389.  show abstract

Harrington, K.J. Bourhis, J. (2016). Reply to N F Saba and S J Wong. Journal of clinical oncology : official journal of the american society of clinical oncology, Vol.34 (17), pp. 2073-2074.

Panek, R. Welsh, L. Dunlop, A. Wong, K.H. Riddell, A.M. Koh, D.-. Schmidt, M.A. Doran, S. Mcquaid, D. Hopkinson, G. Richardson, C. Nutting, C.M. Bhide, S.A. Harrington, K.J. Robinson, S.P. Newbold, K.L. Leach, M.O. (2016). Repeatability and sensitivity of T2* measurements in patients with head and neck squamous cell carcinoma at 3T. Journal of magnetic resonance imaging : jmri, Vol.44 (1), pp. 72-80.  show abstract

McEntee, G. Kyula, J.N. Mansfield, D. Smith, H. Wilkinson, M. Gregory, C. Roulstone, V. Coffey, M. Harrington, K.J. (2016). Enhanced cytotoxicity of reovirus and radiotherapy in melanoma cells is mediated through increased viral replication and mitochondrial apoptotic signalling. Oncotarget, Vol.7 (30), pp. 48517-48532.  show abstract

Dean, J.A. Wong, K.H. Welsh, L.C. Jones, A.-. Schick, U. Newbold, K.L. Bhide, S.A. Harrington, K.J. Nutting, C.M. Gulliford, S.L. (2016). Normal tissue complication probability (NTCP) modelling using spatial dose metrics and machine learning methods for severe acute oral mucositis resulting from head and neck radiotherapy. Radiotherapy and oncology : journal of the european society for therapeutic radiology and oncology, Vol.120 (1), pp. 21-27.  show abstract

Gujral, D.M. Cheung, W.K. Shah, B.N. Chahal, N.S. Bhattacharyya, S. Hooper, J. Senior, R. Tang, M.-. Harrington, K.J. Nutting, C.M. (2016). Contrast enhancement of carotid adventitial vasa vasorum as a biomarker of radiation-induced atherosclerosis. Radiotherapy and oncology : journal of the european society for therapeutic radiology and oncology, Vol.120 (1), pp. 63-68.  show abstract

McQuaid, D. Dunlop, A. Nill, S. Franzese, C. Nutting, C.M. Harrington, K.J. Newbold, K.L. Bhide, S.A. (2016). Evaluation of radiotherapy techniques for radical treatment of lateralised oropharyngeal cancers : Dosimetry and NTCP. Strahlentherapie und onkologie : organ der deutschen rontgengesellschaft ... [et al], Vol.192 (8), pp. 516-525.  show abstract

Miah, A.B. Bhide, S.A. Del Rosario, L. Matthews, J. Nicol, R. Tanay, M.A. Gupta, S. Zaidi, S.H. Newbold, K.L. Harrington, K.J. Nutting, C.M. (2016). Induction Chemotherapy Followed by Chemo-intensity-modulated Radiotherapy for Locally Advanced Nasopharyngeal Cancer. Clinical oncology (royal college of radiologists (great britain)), Vol.28 (8), pp. e61-e67.  show abstract

Miah, A.B. Gulliford, S.L. Morden, J. Newbold, K.L. Bhide, S.A. Zaidi, S.H. Hall, E. Harrington, K.J. Nutting, C.M. (2016). Recovery of Salivary Function: Contralateral Parotid-sparing Intensity-modulated Radiotherapy versus Bilateral Superficial Lobe Parotid-sparing Intensity-modulated Radiotherapy. Clinical oncology (royal college of radiologists (great britain)), Vol.28 (9), pp. e69-e76.  show abstract

Wilkinson, M.J. Smith, H.G. Pencavel, T.D. Mansfield, D.C. Kyula-Currie, J. Khan, A.A. McEntee, G. Roulstone, V. Hayes, A.J. Harrington, K.J. (2016). Isolated limb perfusion with biochemotherapy and oncolytic virotherapy combines with radiotherapy and surgery to overcome treatment resistance in an animal model of extremity soft tissue sarcoma. International journal of cancer, Vol.139 (6), pp. 1414-1422.  show abstract

Bhide, S.A. Thway, K. Lee, J. Wong, K. Clarke, P. Newbold, K.L. Nutting, C.M. Harrington, K.J. (2016). Delayed DNA double-strand break repair following platin-based chemotherapy predicts treatment response in head and neck squamous cell carcinoma. British journal of cancer, Vol.115 (7), pp. 825-830.  show abstract

Barker, H.E. Patel, R. McLaughlin, M. Schick, U. Zaidi, S. Nutting, C.M. Newbold, K.L. Bhide, S. Harrington, K.J. (2016). CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based Chemoradiotherapy. Molecular cancer therapeutics, Vol.15 (9), pp. 2042-2054.  show abstract

Richards, T.M. Bhide, S.A. Miah, A.B. Del Rosario, L. Bodla, S. Thway, K. Gujral, D.M. Rooney, K.P. Schick, U. McGovern, T. Grove, L. Newbold, K.L. Harrington, K.J. Nutting, C.M. (2016). Total Mucosal Irradiation with Intensity-modulated Radiotherapy in Patients with Head and Neck Carcinoma of Unknown Primary: A Pooled Analysis of Two Prospective Studies. Clinical oncology (royal college of radiologists (great britain)), Vol.28 (9), pp. e77-e84.  show abstract

Sharma, R.A. Plummer, R. Stock, J.K. Greenhalgh, T.A. Ataman, O. Kelly, S. Clay, R. Adams, R.A. Baird, R.D. Billingham, L. Brown, S.R. Buckland, S. Bulbeck, H. Chalmers, A.J. Clack, G. Cranston, A.N. Damstrup, L. Ferraldeschi, R. Forster, M.D. Golec, J. Hagan, R.M. Hall, E. Hanauske, A.-. Harrington, K.J. Haswell, T. Hawkins, M.A. Illidge, T. Jones, H. Kennedy, A.S. McDonald, F. Melcher, T. O'Connor, J.P. Pollard, J.R. Saunders, M.P. Sebag-Montefiore, D. Smitt, M. Staffurth, J. Stratford, I.J. Wedge, S.R. NCRI CTRad Academia-Pharma Joint Working Group, (2016). Clinical development of new drug-radiotherapy combinations. Nature reviews. clinical oncology, Vol.13 (10), pp. 627-642.  show abstract

Panek, R. Schmidt, M.A. Borri, M. Koh, D.-. Riddell, A. Welsh, L. Dunlop, A. Powell, C. Bhide, S.A. Nutting, C.M. Harrington, K.J. Newbold, K.L. Leach, M.O. (2016). Time-resolved angiography with stochastic trajectories for dynamic contrast-enhanced MRI in head and neck cancer: Are pharmacokinetic parameters affected?. Medical physics, Vol.43 (11), pp. 6024-?.  show abstract

Dean, J.A. Wong, K.H. Gay, H. Welsh, L.C. Jones, A.-. Schick, U. Oh, J.H. Apte, A. Newbold, K.L. Bhide, S.A. Harrington, K.J. Deasy, J.O. Nutting, C.M. Gulliford, S.L. (2016). Functional Data Analysis Applied to Modeling of Severe Acute Mucositis and Dysphagia Resulting From Head and Neck Radiation Therapy. International journal of radiation oncology, biology, physics, Vol.96 (4), pp. 820-831.  show abstract

Schache, A.G. Powell, N.G. Cuschieri, K.S. Robinson, M. Leary, S. Mehanna, H. Rapozo, D. Long, A. Cubie, H. Junor, E. Monaghan, H. Harrington, K.J. Nutting, C.M. Schick, U. Lau, A.S. Upile, N. Sheard, J. Brougham, K. West, C.M. Oguejiofor, K. Thomas, S. Ness, A.R. Pring, M. Thomas, G.J. King, E.V. McCance, D.J. James, J.A. Moran, M. Sloan, P. Shaw, R.J. Evans, M. Jones, T.M. (2016). HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology. Cancer research, Vol.76 (22), pp. 6598-6606.  show abstract

Ferris, R.L. Blumenschein, G. Fayette, J. Guigay, J. Colevas, A.D. Licitra, L. Harrington, K. Kasper, S. Vokes, E.E. Even, C. Worden, F. Saba, N.F. Iglesias Docampo, L.C. Haddad, R. Rordorf, T. Kiyota, N. Tahara, M. Monga, M. Lynch, M. Geese, W.J. Kopit, J. Shaw, J.W. Gillison, M.L. (2016). Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. The new england journal of medicine, Vol.375 (19), pp. 1856-1867.  show abstract

Wong, K.H. Panek, R. Welsh, L. Mcquaid, D. Dunlop, A. Riddell, A. Murray, I. Du, Y. Chua, S. Koh, D.-. Bhide, S. Nutting, C. Oyen, W.J. Harrington, K. Newbold, K.L. (2016). The Predictive Value of Early Assessment After 1 Cycle of Induction Chemotherapy with 18F-FDG PET/CT and Diffusion-Weighted MRI for Response to Radical Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma. Journal of nuclear medicine : official publication, society of nuclear medicine, Vol.57 (12), pp. 1843-1850.  show abstract

Wilkinson, M.J. Smith, H.G. McEntee, G. Kyula-Currie, J. Pencavel, T.D. Mansfield, D.C. Khan, A.A. Roulstone, V. Hayes, A.J. Harrington, K.J. (2016). Oncolytic vaccinia virus combined with radiotherapy induces apoptotic cell death in sarcoma cells by down-regulating the inhibitors of apoptosis. Oncotarget, Vol.7 (49), pp. 81208-81222.  show abstract

Morgan, R. Simpson, G. Gray, S. Gillett, C. Tabi, Z. Spicer, J. Harrington, K.J. Pandha, H.S. (2016). HOX transcription factors are potential targets and markers in malignant mesothelioma. Bmc cancer, Vol.16 (1).

Andtbacka, R.H. Agarwala, S.S. Ollila, D.W. Hallmeyer, S. Milhem, M. Amatruda, T. Nemunaitis, J.J. Harrington, K.J. Chen, L. Shilkrut, M. Ross, M. Kaufman, H.L. (2016). Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma. Head & neck, Vol.38 (12), pp. 1752-1758.  show abstract

Kaufman, H.L. Amatruda, T. Reid, T. Gonzalez, R. Glaspy, J. Whitman, E. Harrington, K. Nemunaitis, J. Zloza, A. Wolf, M. Senzer, N.N. (2016). Systemic versus local responses in melanoma patients treated with talimogene laherparepvec from a multi-institutional phase II study. Journal for immunotherapy of cancer, Vol.4 (1).

Andtbacka, R.H. Kaufman, H.L. Collichio, F. Amatruda, T. Senzer, N. Chesney, J. Delman, K.A. Spitler, L.E. Puzanov, I. Agarwala, S.S. Milhem, M. Cranmer, L. Curti, B. Lewis, K. Ross, M. Guthrie, T. Linette, G.P. Daniels, G.A. Harrington, K. Middleton, M.R. Miller, W.H. Zager, J.S. Ye, Y. Yao, B. Li, A. Doleman, S. VanderWalde, A. Gansert, J. Coffin, R.S. (2015). Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma. Journal of clinical oncology, Vol.33 (25), pp. 2780-2788.  show abstract

Bogaerts, J. Sydes, M.R. Keat, N. McConnell, A. Benson, A. Ho, A. Roth, A. Fortpied, C. Eng, C. Peckitt, C. Coens, C. Pettaway, C. Arnold, D. Hall, E. Marshall, E. Sclafani, F. Hatcher, H. Earl, H. Ray-Coquard, I. Paul, J. Blay, J.-. Whelan, J. Panageas, K. Wheatley, K. Harrington, K. Licitra, L. Billingham, L. Hensley, M. McCabe, M. Patel, P.M. Carvajal, R. Wilson, R. Glynne-Jones, R. McWilliams, R. Leyvraz, S. Rao, S. Nicholson, S. Filiaci, V. Negrouk, A. Lacombe, D. Dupont, E. Pauporté, I. Welch, J.J. Law, K. Trimble, T. Seymour, M. (2015). Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative. Eur j cancer, Vol.51 (3), pp. 271-281.  show abstract

Seth, R. Khan, A.A. Pencavel, T.D. Wilkinson, M.J. Kyula, J.N. Simpson, G. Pandha, H. Melcher, A. Vile, R. Harris, P.A. Harrington, K.J. (2015). Adenovirally delivered enzyme prodrug therapy with herpes simplex virus-thymidine kinase in composite tissue free flaps shows therapeutic efficacy in rat models of glioma. Plast reconstr surg, Vol.135 (2), pp. 475-487.  show abstract

Harrington, K.J. Puzanov, I. Hecht, J.R. Hodi, F.S. Szabo, Z. Murugappan, S. Kaufman, H.L. (2015). Clinical development of talimogene laherparepvec (T-VEC): a modified herpes simplex virus type-1–derived oncolytic immunotherapy. Expert review of anticancer therapy, Vol.15 (12), pp. 1389-1403.

Appleton, E.S. Turnbull, S. Ralph, C. West, E. Scott, K. Harrington, K. Pandha, H. Melcher, A. (2015). Talimogene laherparepvec in the treatment of melanoma. Expert opinion on biological therapy, Vol.15 (10), pp. 1517-1530.

Dean, J.A. Welsh, L.C. Gulliford, S.L. Harrington, K.J. Nutting, C.M. (2015). A novel method for delineation of oral mucosa for radiotherapy dose–response studies. Radiotherapy and oncology, Vol.115 (1), pp. 63-66.

Roulstone, V. Pedersen, M. Kyula, J. Mansfield, D. Khan, A.A. McEntee, G. Wilkinson, M. Karapanagiotou, E. Coffey, M. Marais, R. Jebar, A. Errington-Mais, F. Melcher, A. Vile, R. Pandha, H. McLaughlin, M. Harrington, K.J. (2015). BRAF- and MEK-Targeted Small Molecule Inhibitors Exert Enhanced Antimelanoma Effects in Combination With Oncolytic Reovirus Through ER Stress. Mol ther, Vol.23 (5), pp. 931-942.  show abstract

Zaidi, S. Blanchard, M. Shim, K. Ilett, E. Rajani, K. Parrish, C. Boisgerault, N. Kottke, T. Thompson, J. Celis, E. Pulido, J. Selby, P. Pandha, H. Melcher, A. Harrington, K. Vile, R. (2015). Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine Melanoma Model After Treatment With Immunomodulatory Agents. Mol ther, Vol.23 (5), pp. 845-856.  show abstract

Miah, A.B. Schick, U. Bhide, S.A. Guerrero-Urbano, M.-. Clark, C.H. Bidmead, A.M. Bodla, S. Del Rosario, L. Thway, K. Wilson, P. Newbold, K.L. Harrington, K.J. Nutting, C.M. (2015). A phase II trial of induction chemotherapy and chemo-IMRT for head and neck squamous cell cancers at risk of bilateral nodal spread: the application of a bilateral superficial lobe parotid-sparing IMRT technique and treatment outcomes. Br j cancer, Vol.112 (1), pp. 32-38.  show abstract

Barker, H.E. Paget, J.T. Khan, A.A. Harrington, K.J. (2015). The tumour microenvironmentafter radiotherapy: mechanisms ofresistance and recurrence. Nature reviews cancer, Vol.15, pp. 409-425.  show abstract

Cheung, W.K. Gujral, D.M. Shah, B.N. Chahal, N.S. Bhattacharyya, S. Cosgrove, D.O. Eckersley, R.J. Harrington, K.J. Senior, R. Nutting, C.M. Tang, M.-. (2015). Attenuation Correction and Normalisation for Quantification of Contrast Enhancement in Ultrasound Images of Carotid Arteries. Ultrasound in medicine & biology, Vol.41 (7), pp. 1876-1883.

Barker, H.E. Paget, J.T. Khan, A.A. Harrington, K.J. (2015). Erratum: The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nature reviews cancer, Vol.15 (8), pp. 509-509.

Dillon, M.T. Harrington, K.J. (2015). Human Papillomavirus-Negative Pharyngeal Cancer. Journal of clinical oncology : official journal of the american society of clinical oncology, Vol.33 (29), pp. 3251-3261.  show abstract

Harrington, K. Temam, S. Mehanna, H. D'Cruz, A. Jain, M. D'Onofrio, I. Manikhas, G. Horvath, Z. Sun, Y. Dietzsch, S. Dubinsky, P. Holeckova, P. El-Hariry, I. Franklin, N. Biswas-Baldwin, N. Legenne, P. Wissel, P. Netherway, T. Farrell, J. Ellis, C. Wang-Silvanto, J. Amonkar, M. Ahmed, N. Santillana, S. Bourhis, J. (2015). Postoperative Adjuvant Lapatinib and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib Monotherapy in High-Risk Patients With Resected Squamous Cell Carcinoma of the Head and Neck: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study. Journal of clinical oncology, Vol.33 (35), pp. 4202-4209.  show abstract

Otter, S. Schick, U. Gulliford, S. Lal, P. Franceschini, D. Newbold, K. Nutting, C. Harrington, K. Bhide, S. (2015). Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose Distributions. International journal of radiation oncology*biology*physics, Vol.93 (3), pp. 507-515.

Wilkins, A. Furness, A. Corbett, R.W. Bloomfield, A. Porta, N. Morris, S. Ali, Z. Larkin, J. Harrington, K. (2015). The melanoma-specific graded prognostic assessment does not adequately discriminate prognosis in a modern population with brain metastases from malignant melanoma. British journal of cancer, Vol.113 (9), pp. 1275-1281.  show abstract

Schick, U. Kyula, J. Barker, H. Patel, R. Zaidi, S. Gregory, C. Hafsi, H. Roulstone, V. Deutsch, E. McLaughlin, M. Harrington, K. (2015). Trametinib radiosensitises RAS- and BRAF-mutated melanoma by perturbing cell cycle and inducing senescence. Radiotherapy and oncology, Vol.117 (2), pp. 364-375.

Blanchard, M. Shim, K.G. Grams, M.P. Rajani, K. Diaz, R.M. Furutani, K.M. Thompson, J. Olivier, K.R. Park, S.S. Markovic, S.N. Pandha, H. Melcher, A. Harrington, K. Zaidi, S. Vile, R. (2015). Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy. International journal of radiation oncology*biology*physics, Vol.93 (3), pp. 577-587.

Dunlop, A. McQuaid, D. Nill, S. Murray, J. Poludniowski, G. Hansen, V.N. Bhide, S. Nutting, C. Harrington, K. Newbold, K. Oelfke, U. (2015). Comparison of CT number calibration techniques for CBCT-based dose calculation. Strahlentherapie und onkologie, Vol.191 (12), pp. 970-978.

Welsh, L. Panek, R. McQuaid, D. Dunlop, A. Schmidt, M. Riddell, A. Koh, D.-. Doran, S. Murray, I. Du, Y. Chua, S. Hansen, V. Wong, K.H. Dean, J. Gulliford, S. Bhide, S. Leach, M.O. Nutting, C. Harrington, K. Newbold, K. (2015). Prospective, longitudinal, multi-modal functional imaging for radical chemo-IMRT treatment of locally advanced head and neck cancer: the INSIGHT study. Radiation oncology (london, england), Vol.10, pp. 112-?.  show abstract

Roulstone, V. Khan, K. Pandha, H.S. Rudman, S. Coffey, M. Gill, G.M. Melcher, A.A. Vile, R. Harrington, K.J. de Bono, J. Spicer, J. (2015). Phase I trial of cyclophosphamide as an immune modulator for optimizing oncolytic reovirus delivery to solid tumors. Clin cancer res, Vol.21 (6), pp. 1305-1312.  show abstract

Pencavel, T.D. Wilkinson, M.J. Mansfield, D.C. Khan, A.A. Seth, R. Karapanagiotou, E.M. Roulstone, V. Aguilar, R.J. Chen, N.G. Szalay, A.A. Hayes, A.J. Harrington, K.J. (2015). Isolated limb perfusion with melphalan, tumour necrosis factor-alpha and oncolytic vaccinia virus improves tumour targeting and prolongs survival in a rat model of advanced extremity sarcoma. Int j cancer, Vol.136 (4), pp. 965-976.  show abstract

Jennings, V.A. Ilett, E.J. Scott, K.J. West, E.J. Vile, R. Pandha, H. Harrington, K. Young, A. Hall, G.D. Coffey, M. Selby, P. Errington-Mais, F. Melcher, A.A. (2014). Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites. International journal of cancer, Vol.134 (5), pp. 1091-1101.

Gujral, D.M. Chahal, N. Senior, R. Harrington, K.J. Nutting, C.M. (2014). Radiation-induced carotid artery atherosclerosis. Radiother oncol, Vol.110 (1), pp. 31-38.  show abstract

Taylor, G.S. Jia, H. Harrington, K. Lee, L.W. Turner, J. Ladell, K. Price, D.A. Tanday, M. Matthews, J. Roberts, C. Edwards, C. McGuigan, L. Hartley, A. Wilson, S. Hui, E.P. Chan, A.T. Rickinson, A.B. Steven, N.M. (2014). A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancer. Clin cancer res, Vol.20 (19), pp. 5009-5022.  show abstract

Gujral, D.M. Piercy, D. Morden, J.P. Emson, M. Hall, E. Miah, A.B. Bhide, S.A. Newbold, K.L. Harrington, K.J. Nutting, C.M. (2014). Current attitudes of head and neck oncologists in the United Kingdom to induction chemotherapy for locally advanced head and neck cancer: a survey of centres participating in a national randomised controlled trial. Oral oncol, Vol.50 (2), pp. 141-146.  show abstract

Gujral, D.M. Shah, B.N. Chahal, N.S. Senior, R. Harrington, K.J. Nutting, C.M. (2014). Clinical features of radiation-induced carotid atherosclerosis. Clin oncol (r coll radiol), Vol.26 (2), pp. 94-102.  show abstract

Powell, C. Schick, U. Morden, J.P. Gulliford, S.L. Miah, A.B. Bhide, S. Newbold, K. Harrington, K.J. Nutting, C.M. (2014). Fatigue during chemoradiotherapy for nasopharyngeal cancer and its relationship to radiation dose distribution in the brain. Radiother oncol, Vol.110 (3), pp. 416-421.  show abstract

Sarris, E.G. Harrington, K.J. Saif, M.W. Syrigos, K.N. (2014). Multimodal treatment strategies for elderly patients with head and neck cancer. Cancer treat rev, Vol.40 (3), pp. 465-475.  show abstract

Dillon, M.T. Good, J.S. Harrington, K.J. (2014). Selective targeting of the G2/M cell cycle checkpoint to improve the therapeutic index of radiotherapy. Clin oncol (r coll radiol), Vol.26 (5), pp. 257-265.  show abstract

Morgan, R. Boxall, A. Harrington, K.J. Simpson, G.R. Michael, A. Pandha, H.S. (2014). Targeting HOX transcription factors in prostate cancer. Bmc urology, Vol.14.

Dunlop, A. Welsh, L. Nutting, C. Harrington, K. Bhide, S. Newbold, K. (2014). SU-E-T-198: Hippocampal-Sparing Radiotherapy (HSRT) for Patients with Head and Neck Cancer (HNC) Using Intensity-Modulated Radiation Therapy (IMRT). Medical physics, Vol.41 (6Part14), pp. 268-268.

Dean, J. Welsh, L. Gulliford, S. Harrington, K. Nutting, C. (2014). SU-D-16A-02: A Novel Methodology for Accurate, Semi-Automated Delineation of Oral Mucosa for Radiation Therapy Dose-Response Studies. Medical physics, Vol.41 (6Part3), pp. 108-108.

Nemunaitis, J.J. Andtbacka, R.H. Ross, M. Amatruda, T. Chesney, J. Collichio, F.A. Harrington, K.J. Steven, N.M. Fourie, S. Dreosti, L. Li, A. Liu, K. Shilkrut, M. Coffin, R. Kaufman, H. (2014). Results of the Extension Trial of Optim, a Multicenter, Randomized Phase 3 Trial of Talimogene Laherparepvec (T-Vec) Vs Gm-Csf for Unresected Stage Iiib-Iv Melanoma. Annals of oncology, Vol.25, pp. iv382-iv382.

Lynch, J. Lal, P. Schick, U. Nutting, C.M. Newbold, K. Harrington, K. Bhide, S. (2014). Multiple cervical lymph node involvement and extra-capsular extension predict for contralateral nodal recurrence after ipsilateral radiotherapy for squamous cell carcinoma of the tonsil. Oral oncol, Vol.50 (9), pp. 901-906.  show abstract

Irune, E. Dwivedi, R.C. Nutting, C.M. Harrington, K.J. (2014). Treatment-related dysgeusia in head and neck cancer patients. Cancer treat rev, Vol.40 (9), pp. 1106-1117.  show abstract

Morgan, R. Gray, S. Gillett, C. Tabi, Z. Launchbury, F. Spicer, J. Harrington, K. Pandha, H.S. (2014). HOX TRANSCRIPTION FACTORS ARE POTENTIAL TARGETS AND MARKERS IN MALIGNANT MESOTHELIOMA. Anticancer research, Vol.34 (10), pp. 6069-6071.

Ilett, E. Kottke, T. Donnelly, O. Thompson, J. Willmon, C. Diaz, R. Zaidi, S. Coffey, M. Selby, P. Harrington, K. Pandha, H. Melcher, A. Vile, R. (2014). Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virus. Mol ther, Vol.22 (10), pp. 1851-1863.  show abstract

Alonso-Camino, V. Rajani, K. Kottke, T. Rommelfanger-Konkol, D. Zaidi, S. Thompson, J. Pulido, J. Ilett, E. Donnelly, O. Selby, P. Pandha, H. Melcher, A. Harrington, K. Diaz, R.M. Vile, R. (2014). The Profile of Tumor Antigens Which Can be Targeted by Immunotherapy Depends Upon the Tumor's Anatomical Site. Molecular therapy, Vol.22 (11), pp. 1936-1948.

Gujral, D.M. Miah, A.B. Bodla, S. Richards, T.M. Welsh, L. Schick, U. Powell, C.J. Clark, C.H. Bidmead, M.A. Grove, L. Guerrero-Urbano, T. Bhide, S.A. Newbold, K.L. Harrington, K.J. Nutting, C.M. (2014). Final long-term results of a phase I/II study of dose-escalated intensity-modulated radiotherapy for locally advanced laryngo-hypopharyngeal cancers. Oral oncol, Vol.50 (11), pp. 1089-1097.  show abstract

Alonso-Camino, V. Rajani, K. Kottke, T. Rommelfanger-Konkol, D. Zaidi, S. Thompson, J. Pulido, J. Ilett, E. Donnelly, O. Selby, P. Pandha, H. Melcher, A. Harrington, K. Diaz, R.M. Vile, R. (2014). The profile of tumor antigens which can be targeted by immunotherapy depends upon the tumor's anatomical site. Mol ther, Vol.22 (11), pp. 1936-1948.  show abstract

Roe, J.W. Drinnan, M.J. Carding, P.N. Harrington, K.J. Nutting, C.M. (2014). Patient-reported outcomes following parotid-sparing intensity-modulated radiotherapy for head and neck cancer How important is dysphagia?. Oral oncol, Vol.50 (12), pp. 1182-1187.  show abstract

Welsh, L.C. Dunlop, A.W. McGovern, T. McQuaid, D. Dean, J.A. Gulliford, S.L. Bhide, S.A. Harrington, K.J. Nutting, C.M. Newbold, K.L. (2014). Neurocognitive function after (chemo)-radiotherapy for head and neck cancer. Clin oncol (r coll radiol), Vol.26 (12), pp. 765-775.  show abstract

Kyula, J.N. Khan, A.A. Mansfield, D. Karapanagiotou, E.M. McLaughlin, M. Roulstone, V. Zaidi, S. Pencavel, T. Touchefeu, Y. Seth, R. Chen, N.G. Yu, Y.A. Zhang, Q. Melcher, A.A. Vile, R.G. Pandha, H.S. Ajaz, M. Szalay, A.A. Harrington, K.J. (2014). Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in (V600D/E)BRAF mutant melanoma depends on JNK and TNF-α signaling. Oncogene, Vol.33 (13), pp. 1700-1712.  show abstract

Burtness, B. Bourhis, J.P. Vermorken, J.B. Harrington, K.J. Cohen, E.E. (2014). Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial. Trials, Vol.15.

Dean, J.A. Welsh, L.C. Harrington, K.J. Nutting, C.M. Gulliford, S. (2014). Predictive Modelling of Toxicity Resulting from Radiotherapy Treatments of Head and Neck Cancer. Corr, Vol.abs/1412.6399.

Donnelly, O.G. Errington-Mais, F. Steele, L. Hadac, E. Jennings, V. Scott, K. Peach, H. Phillips, R.M. Bond, J. Pandha, H. Harrington, K. Vile, R. Russell, S. Selby, P. Melcher, A.A. (2013). Measles virus causes immunogenic cell death in human melanoma. Gene therapy, Vol.20 (1), pp. 7-15.

Powell, C. Schmidt, M. Borri, M. Koh, D.-. Partridge, M. Riddell, A. Cook, G. Bhide, S.A. Nutting, C.M. Harrington, K.J. Newbold, K.L. (2013). Changes in functional imaging parameters following induction chemotherapy have important implications for individualised patient-based treatment regimens for advanced head and neck cancer. Radiother oncol, Vol.106 (1), pp. 112-117.  show abstract

Mansfield, D. Pencavel, T. Kyula, J.N. Zaidi, S. Roulstone, V. Thway, K. Karapanagiotou, L. Khan, A.A. McLaughlin, M. Touchefeu, Y. Seth, R. Melcher, A.A. Vile, R.G. Pandha, H.S. Harrington, K.J. (2013). Oncolytic Vaccinia virus and radiotherapy in head and neck cancer. Oral oncology, Vol.49 (2), pp. 108-118.

Miah, A.B. Gulliford, S.L. Bhide, S.A. Zaidi, S.H. Newbold, K.L. Harrington, K.J. Nutting, C.M. (2013). The effect of concomitant chemotherapy on parotid gland function following head and neck IMRT. Radiother oncol, Vol.106 (3), pp. 346-351.  show abstract

Miah, A.B. Gulliford, S.L. Clark, C.H. Bhide, S.A. Zaidi, S.H. Newbold, K.L. Harrington, K.J. Nutting, C.M. (2013). Dose-response analysis of parotid gland function: what is the best measure of xerostomia?. Radiother oncol, Vol.106 (3), pp. 341-345.  show abstract

Roulstone, V. Twigger, K. Zaidi, S. Pencavel, T. Kyula, J.N. White, C. McLaughlin, M. Seth, R. Karapanagiotou, E.M. Mansfield, D. Coffey, M. Nuovo, G. Vile, R.G. Pandha, H.S. Melcher, A.A. Harrington, K.J. (2013). Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin-paclitaxel doublet chemotherapy. Gene therapy, Vol.20 (5), pp. 521-528.

Franzese, C. Gujral, D.M. Good, J. Thway, K. Harrington, K.J. (2013). Radical radiotherapy for radiation-induced malignancy in the context of Hereditary retinoblastoma. Clin oncol (r coll radiol), Vol.25 (5), pp. 330-331.

Welsh, L. Powell, C. Pratt, B. Harrington, K. Nutting, C. Harmer, C. Newbold, K. (2013). Long-term outcomes following low-dose radioiodide ablation for differentiated thyroid cancer. J clin endocrinol metab, Vol.98 (5), pp. 1819-1825.  show abstract

Harrington, K. Berrier, A. Robinson, M. Remenar, E. Housset, M. de Mendoza, F.H. Fayette, J. Mehanna, H. El-Hariry, I. Compton, N. Franklin, N. Biswas-Baldwin, N. Lau, M. Legenne, P. Kumar, R. (2013). Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative disease. Eur j cancer, Vol.49 (7), pp. 1609-1618.  show abstract

Wilkins, A.C. Rosenfelder, N. Schick, U. Gupta, S. Thway, K. Nutting, C.M. Harrington, K.J. Newbold, K. Bhide, S.A. (2013). Equivalence of cisplatin and carboplatin-based chemoradiation for locally advanced squamous cell carcinoma of the head and neck: a matched-pair analysis. Oral oncol, Vol.49 (6), pp. 615-619.  show abstract

Giannopoulou, A. Gkiozos, I. Harrington, K.J. Syrigos, K.N. (2013). Thymoma and radiation therapy: a systematic review of medical treatment. Expert review of anticancer therapy, Vol.13 (6), pp. 759-766.

Calvo, F. Ege, N. Grande-Garcia, A. Hooper, S. Jenkins, R.P. Chaudhry, S.I. Harrington, K. Williamson, P. Moeendarbary, E. Charras, G. Sahai, E. (2013). Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nature cell biology, Vol.15 (6), pp. 637-+.

Box, C. Mendiola, M. Gowan, S. Box, G.M. Valenti, M. Brandon, A.D. Al-Lazikani, B. Rogers, S.J. Wilkins, A. Harrington, K.J. Eccles, S.A. (2013). A novel serum protein signature associated with resistance to epidermal growth factor receptor tyrosine kinase inhibitors in head and neck squamous cell carcinoma. Eur j cancer, Vol.49 (11), pp. 2512-2521.  show abstract

Touchefeu, Y. Khan, A.A. Borst, G. Zaidi, S.H. McLaughlin, M. Roulstone, V. Mansfield, D. Kyula, J. Pencavel, T. Karapanagiotou, E.M. Clayton, J. Federspiel, M.J. Russell, S.J. Garrett, M. Collins, I. Harrington, K.J. (2013). Optimising measles virus-guided radiovirotherapy with external beam radiotherapy and specific checkpoint kinase 1 inhibition. Radiotherapy and oncology, Vol.108 (1), pp. 24-31.

Perlikos, F. Harrington, K.J. Syrigos, K.N. (2013). Key molecular mechanisms in lung cancer invasion and metastasis: A comprehensive review. Critical reviews in oncology hematology, Vol.87 (1), pp. 1-11.

Chaudhry, S.I. Hooper, S. Nye, E. Williamson, P. Harrington, K. Sahai, E. (2013). Autocrine IL-1 beta-TRAF6 signalling promotes squamous cell carcinoma invasion through paracrine INF alpha, signalling to carcinoma-associated fibroblasts. Oncogene, Vol.32 (6), pp. 747-758.

Boisgerault, N. Kottke, T. Pulido, J. Thompson, J. Diaz, R.M. Rommelfanger-Konkol, D. Embry, A. Saenz, D. Poeschla, E. Pandha, H. Harrington, K. Melcher, A. Selby, P. Vile, R. (2013). Functional Cloning of Recurrence-specific Antigens Identifies Molecular Targets to Treat Tumor Relapse. Molecular therapy, Vol.21 (8), pp. 1507-1516.

Donnelly, O. Harrington, K. Melcher, A. Pandha, H. (2013). Live viruses to treat cancer. Journal of the royal society of medicine, Vol.106 (8), pp. 310-314.

Kyula, J.N. Khan, A.A. Wilkinson, M.J. Mansfield, D. Harrington, K.J. (2013). Radiation lays down covering fire for viral shock troops. Oncotarget, Vol.4, pp. 1329-1330.

Pencavel, T. Seth, R. Khan, A. Wilkinson, M. Hayes, A. Harrington, K. (2013). Isolated limb perfusion with melphalan, tnfa and oncolytic vaccinia virus delays tumour growth and prolongs survival in a rat model of locally-advanced extremity sarcoma. Int j surg, Vol.11 (8), p. 590.

Good, J.S. Harrington, K.J. (2013). The hallmarks of cancer and the radiation oncologist: updating the 5Rs of radiobiology. Clin oncol (r coll radiol), Vol.25 (10), pp. 569-577.  show abstract

Kottke, T. Boisgerault, N. Diaz, R.M. Donnelly, O. Rommelfanger-Konkol, D. Pulido, J. Thompson, J. Mukhopadhyay, D. Kaspar, R. Coffey, M. Pandha, H. Melcher, A. Harrington, K. Selby, P. Vile, R. (2013). Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrence. Nature medicine, Vol.19 (12), pp. 1625-1631.

Borst, G.R. McLaughlin, M. Kyula, J.N. Neijenhuis, S. Khan, A. Good, J. Zaidi, S. Powell, N.G. Meier, P. Collins, I. Garrett, M.D. Verheij, M. Harrington, K.J. (2013). Targeted Radiosensitization by the Chk1 Inhibitor SAR-020106. International journal of radiation oncology biology physics, Vol.85 (4), pp. 1110-1118.

Harrington, K.J. (2013). Oncolytic Virotherapy Needs Trials, Not Access Programs. Clinical cancer research, Vol.19 (10), pp. 2595-2597.

Adair, R.A. Scott, K.J. Fraser, S. Errington-Mais, F. Pandha, H. Coffey, M. Selby, P. Cook, G.P. Vile, R. Harrington, K.J. Toogood, G. Melcher, A.A. (2013). Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cells. International journal of cancer, Vol.132 (10), pp. 2327-2338.

Harrington, K.J. (2013). Oncolytic viruses: methods and protocols. Br j cancer, Vol.108 (3), p. 735.

Bhide, S.A. Ahmed, M. Newbold, K. Harrington, K.J. Nutting, C.M. (2012). The role of intensity modulated radiotherapy in advanced oral cavity carcinoma. J cancer res ther, Vol.8 Suppl 1, pp. S67-S71.  show abstract

Karapanagiotou, E.M. Roulstone, V. Twigger, K. Ball, M. Tanay, M. Nutting, C. Newbold, K. Gore, M.E. Larkin, J. Syrigos, K.N. Coffey, M. Thompson, B. Mettinger, K. Vile, R.G. Pandha, H.S. Hall, G.D. Melcher, A.A. Chester, J. Harrington, K.J. (2012). Phase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignancies. Clin cancer res, Vol.18 (7), pp. 2080-2089.  show abstract

Dwivedi, R.C. Rose, S.S. Chisholm, E.J. Kerawala, C.J. Clarke, P.M. Nutting, C.M. Rhys-Evans, P.H. Harrington, K.J. Kazi, R. (2012). Development and validation of first-ever speech-specific perceptual speech evaluation tool for patients with head and neck cancer: the London speech evaluation (LSE) scale. Head neck, Vol.34 (1), pp. 94-103.  show abstract

Schick, U. Gujral, D.M. Richards, T.M. Harrington, K.J. Nutting, C.M. (2012). Zalutumumab in head and neck cancer. Expert opin biol ther, Vol.12 (1), pp. 119-125.  show abstract

Miah, A.B. Bhide, S.A. Guerrero-Urbano, M.T. Clark, C. Bidmead, A.M. St Rose, S. Barbachano, Y. A'hern, R. Tanay, M. Hickey, J. Nicol, R. Newbold, K.L. Harrington, K.J. Nutting, C.M. (2012). Dose-escalated intensity-modulated radiotherapy is feasible and may improve locoregional control and laryngeal preservation in laryngo-hypopharyngeal cancers. Int j radiat oncol biol phys, Vol.82 (2), pp. 539-547.  show abstract

Dwivedi, R.C. St Rose, S. Chisholm, E.J. Youssefi, P. Hassan, M.S. Khan, A.S. Elmiyeh, B. Kerawala, C.J. Clarke, P.M. Nutting, C.M. Rhys-Evans, P.H. Harrington, K.J. Kazi, R. (2012). Evaluation of factors affecting post-treatment quality of life in oral and oropharyngeal cancer patients primarily treated with curative surgery: an exploratory study. Eur arch otorhinolaryngol, Vol.269 (2), pp. 591-599.  show abstract

Roe, J.W. Carding, P.N. Rhys-Evans, P.H. Newbold, K.L. Harrington, K.J. Nutting, C.M. (2012). Assessment and management of dysphagia in patients with head and neck cancer who receive radiotherapy in the United Kingdom - a web-based survey. Oral oncol, Vol.48 (4), pp. 343-348.  show abstract

Buettner, F. Miah, A.B. Gulliford, S.L. Hall, E. Harrington, K.J. Webb, S. Partridge, M. Nutting, C.M. (2012). Novel approaches to improve the therapeutic index of head and neck radiotherapy: an analysis of data from the PARSPORT randomised phase III trial. Radiother oncol, Vol.103 (1), pp. 82-87.  show abstract

Bhide, S.A. Gulliford, S. Schick, U. Miah, A. Zaidi, S. Newbold, K. Nutting, C.M. Harrington, K.J. (2012). Dose-response analysis of acute oral mucositis and pharyngeal dysphagia in patients receiving induction chemotherapy followed by concomitant chemo-IMRT for head and neck cancer. Radiother oncol, Vol.103 (1), pp. 88-91.  show abstract

Dwivedi, R.C. Chisholm, E.J. Khan, A.S. Harris, N.J. Bhide, S.A. St Rose, S. Kerawala, C.J. Clarke, P.M. Nutting, C.M. Rhys-Evans, P.H. Harrington, K.J. Kazi, R. (2012). An exploratory study of the influence of clinico-demographic variables on swallowing and swallowing-related quality of life in a cohort of oral and oropharyngeal cancer patients treated with primary surgery. Eur arch otorhinolaryngol, Vol.269 (4), pp. 1233-1239.  show abstract

Touchefeu, Y. Schick, U. Harrington, K.J. (2012). [Measles virus: a future therapeutic agent in oncology?]. Med sci (paris), Vol.28 (4), pp. 388-394.  show abstract

Pulido, J. Kottke, T. Thompson, J. Galivo, F. Wongthida, P. Diaz, R.M. Rommelfanger, D. Ilett, E. Pease, L. Pandha, H. Harrington, K. Selby, P. Melcher, A. Vile, R. (2012). Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma. Nature biotechnology, Vol.30 (4), pp. 336-343.

Bhide, S.A. Newbold, K.L. Harrington, K.J. Nutting, C.M. (2012). Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers. Br j radiol, Vol.85 (1013), pp. 487-494.  show abstract

Dwivedi, R.C. St Rose, S. Chisholm, E.J. Bisase, B. Amen, F. Nutting, C.M. Clarke, P.M. Kerawala, C.J. Rhys-Evans, P.H. Harrington, K.J. Kazi, R. (2012). Evaluation of speech outcomes using English version of the Speech Handicap Index in a cohort of head and neck cancer patients. Oral oncol, Vol.48 (6), pp. 547-553.  show abstract

Murray, J.R. Williams, G.R. Harrington, K.J. Newbold, K. Nutting, C.M. (2012). Rising thyroglobulin tumour marker during pregnancy in a thyroid cancer patient: no cause for alarm?. Clin endocrinol (oxf), Vol.77 (1), pp. 155-157.

Donnelly, O.G. Errington-Mais, F. Prestwich, R. Harrington, K. Pandha, H. Vile, R. Melcher, A.A. (2012). Recent Clinical Experience with Oncolytic Viruses. Current pharmaceutical biotechnology, Vol.13 (9), pp. 1834-1841.

Gulliford, S.L. Miah, A.B. Brennan, S. McQuaid, D. Clark, C.H. Partridge, M. Harrington, K.J. Morden, J.P. Hall, E. Nutting, C.M. (2012). Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trial. Radiother oncol, Vol.104, pp. 205-212.  show abstract

Khattak, M. Gore, M. Larkin, J. Strauss, D. Thomas, M. Hayes, A. Harrington, K. (2012). Adjuvant nodal irradiation in melanoma. Lancet oncol, Vol.13 (8), pp. e326-e327.

Donnelly, O. Vile, R. Pandha, H. Harrington, K. Melcher, A. (2012). The Hitchhiker's Guide to Virotherapy. Oncotarget, Vol.3 (8), pp. 735-736.

Seth, R. Khan, A.A. Pencavel, T. Harrington, K.J. Harris, P.A. (2012). Targeted gene delivery by free-tissue transfer in oncoplastic reconstruction. Lancet oncol, Vol.13 (9), pp. e392-e402.  show abstract

Nuovo, G.J. Garofalo, M. Valeri, N. Roulstone, V. Volinia, S. Cohn, D.E. Phelps, M. Harrington, K.J. Vile, R. Melcher, A. Galanis, E. Sehl, S. Adair, R. Scott, K. Rose, A. Toogood, G. Coffey, M.C. (2012). Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples. Modern pathology, Vol.25 (10), pp. 1333-1344.

Galanis, E. Markovic, S.N. Suman, V.J. Nuovo, G.J. Vile, R.G. Kottke, T.J. Nevala, W.K. Thompson, M.A. Lewis, J.E. Rumilla, K.M. Roulstone, V. Harrington, K. Linette, G.P. Maples, W.J. Coffey, M. Zwiebel, J. Kendra, K. (2012). Phase II Trial of Intravenous Administration of Reolysin (R) (Reovirus Serotype-3-dearing Strain) in Patients with Metastatic Melanoma. Molecular therapy, Vol.20 (10), pp. 1998-2003.

Morgan, R. Boxall, A. Harrington, K.J. Simpson, G.R. Gillett, C. Michael, A. Pandha, H.S. (2012). Targeting the HOX/PBX dimer in breast cancer. Breast cancer research and treatment, Vol.136 (2), pp. 389-398.

Kyula, J.N. Roulstone, V. Karapanagiotou, E.M. Melcher, A.A. Harrington, K.J. (2012). Oncolytic reovirus type 3 (Dearing) as a novel therapy in head and neck cancer. Expert opinion on biological therapy, Vol.12 (12), pp. 1669-1678.  show abstract

Dwivedi, R.C. St Rose, S. Chisholm, E.J. Georgalas, C. Bisase, B. Amen, F. Kerawala, C.J. Clarke, P.M. Nutting, C.M. Rhys-Evans, P.H. Harrington, K.J. Kazi, R. (2012). Evaluation of swallowing by Sydney Swallow Questionnaire (SSQ) in oral and oropharyngeal cancer patients treated with primary surgery. Dysphagia, Vol.27 (4), pp. 491-497.  show abstract

Adair, R.A. Roulstone, V. Scott, K.J. Morgan, R. Nuovo, G.J. Fuller, M. Beirne, D. West, E.J. Jennings, V.A. Rose, A. Kyula, J. Fraser, S. Dave, R. Anthoney, D.A. Merrick, A. Prestwich, R. Aldouri, A. Donnelly, O. Pandha, H. Coffey, M. Selby, P. Vile, R. Toogood, G. Harrington, K. Melcher, A.A. (2012). Cell Carriage, Delivery, and Selective Replication of an Oncolytic Virus in Tumor in Patients. Science translational medicine, Vol.4 (138).

Twigger, K. Roulstone, V. Kyula, J. Karapanagiotou, E.M. Syrigos, K.N. Morgan, R. White, C. Bhide, S. Nuovo, G. Coffey, M. Thompson, B. Jebar, A. Errington, F. Melcher, A.A. Vile, R.G. Pandha, H.S. Harrington, K.J. (2012). Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway. Bmc cancer, Vol.12, p. 368.  show abstract

Simpson, G.R. Horvath, A. Annels, N.E. Pencavel, T. Metcalf, S. Seth, R. Peschard, P. Price, T. Coffin, R.S. Mostafid, H. Melcher, A.A. Harrington, K.J. Pandha, H.S. (2012). Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer. British journal of cancer, Vol.106 (3), pp. 496-507.

Zaidi, S. McLaughlin, M. Bhide, S.A. Eccles, S.A. Workman, P. Nutting, C.M. Huddart, R.A. Harrington, K.J. (2012). The HSP90 inhibitor NVP-AUY922 radiosensitizes by abrogation of homologous recombination resulting in mitotic entry with unresolved DNA damage. Plos one, Vol.7 (4), p. e35436.  show abstract

Newbold, K.L. Bhide, S. Convery, H. Harrington, K.J. Nutting, C.M. (2012). Prospective intra-patient evaluation of a shoulder retraction device for radiotherapy in head and neck cancer. Med dosim, Vol.37 (3), pp. 293-295.  show abstract

Touchefeu, Y. Franken, P. Harrington, K.J. (2012). Radiovirotherapy: principles and prospects in oncology. Curr pharm des, Vol.18 (22), pp. 3313-3320.  show abstract

Lolkema, M.P. Arkenau, H.-. Harrington, K. Roxburgh, P. Morrison, R. Roulstone, V. Twigger, K. Coffey, M. Mettinger, K. Gill, G. Evans, T.R. de Bono, J.S. (2011). A phase I study of the combination of intravenous reovirus type 3 Dearing and gemcitabine in patients with advanced cancer. Clin cancer res, Vol.17 (3), pp. 581-588.  show abstract

Hidalgo-Carcedo, C. Hooper, S. Chaudhry, S.I. Williamson, P. Harrington, K. Leitinger, B. Sahai, E. (2011). Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6. Nature cell biology, Vol.13 (1), pp. 49-22.

Willmon, C. Diaz, R.M. Wongthida, P. Galivo, F. Kottke, T. Thompson, J. Albelda, S. Harrington, K. Melcher, A. Vile, R. (2011). Vesicular Stomatitis Virus-induced Immune Suppressor Cells Generate Antagonism Between Intratumoral Oncolytic Virus and Cyclophosphamide. Molecular therapy, Vol.19 (1), pp. 140-10.

Whitcher, B. Schmid, V.J. Collins, D.J. Orton, M.R. Koh, D.-. Diaz de Corcuera, I. Parera, M. del Campo, J.M. deSouza, N.M. Leach, M.O. Harrington, K. El-Hariry, I.A. (2011). A Bayesian hierarchical model for DCE-MRI to evaluate treatment response in a phase II study in advanced squamous cell carcinoma of the head and neck. Magnetic resonance materials in physics biology and medicine, Vol.24 (2), pp. 85-12.

Ilett, E.J. Barcena, M. Errington-Mais, F. Griffin, S. Harrington, K.J. Pandha, H.S. Coffey, M. Selby, P.J. Limpens, R.W. Mommaas, M. Hoeben, R.C. Vile, R.G. Melcher, A.A. (2011). Internalization of Oncolytic Reovirus by Human Dendritic Cell Carriers Protects the Virus from Neutralization. Clinical cancer research, Vol.17 (9), pp. 2767-10.

Kottke, T. Errington, F. Pulido, J. Galivo, F. Thompson, J. Wongthida, P. Diaz, R.M. Chong, H. Ilett, E. Chester, J. Pandha, H. Harrington, K. Selby, P. Melcher, A. Vile, R. (2011). Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors. Nature medicine, Vol.17 (7), pp. 854-7.

Syrigos, K.N. Karapanagiotou, E. Boura, P. Manegold, C. Harrington, K. (2011). Bevacizumab-Induced Hypertension Pathogenesis and Management. Biodrugs, Vol.25 (3), pp. 159-11.

Sayed, S.I. Dwivedi, R.C. Katna, R. Garg, A. Pathak, K.A. Nutting, C.M. Rhys-Evans, P. Harrington, K.J. Kazi, R. (2011). Implications of understanding cancer stem cell (CSC) biology in head and neck squamous cell cancer. Oral oncology, Vol.47 (4), pp. 237-7.

Touchefeu, Y. Vassaux, G. Harrington, K.J. (2011). Oncolytic viruses in radiation oncology. Radiotherapy and oncology, Vol.99 (3), pp. 262-9.

Richard-Fiardo, P. Franken, P.R. Harrington, K.J. Vassaux, G. Cambien, B. (2011). The use of molecular imaging of gene expression by radiotracers in gene therapy. Expert opinion on biological therapy, Vol.11 (10), pp. 1273-13.

Dwivedi, R.C. Dwivedi, R.C. Kazi, R. Kanwar, N. Nutting, C.M. Harrington, K.J. Rhys-Evans, P.H. (2011). Should the treatment paradigms for oral and oropharyngeal cancers be changed now: the role of human papilloma virus?. Anz journal of surgery, Vol.81 (9), pp. 581-4.

Kottke, T. Chester, J. Ilett, E. Thompson, J. Diaz, R. Coffey, M. Selby, P. Nuovo, G. Pulido, J. Mukhopadhyay, D. Pandha, H. Harrington, K. Melcher, A. Vile, R. (2011). Precise Scheduling of Chemotherapy Primes VEGF-producing Tumors for Successful Systemic Oncolytic Virotherapy. Molecular therapy, Vol.19 (10), pp. 1802-11.

Harrington, K. (2011). Virotherapy in the UK. Human gene therapy, Vol.22 (10), pp. A12-1.

Nutting, C.M. Morden, J.P. Harrington, K.J. Urbano, T.G. Bhide, S.A. Clark, C. Miles, E.A. Miah, A.B. Newbold, K. Tanay, M. Adab, F. Jefferies, S.J. Scrase, C. Yap, B.K. A'Hern, R.P. Sydenham, M.A. Emson, M. Hall, E. PARSPORT trial management group, (2011). Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet oncol, Vol.12 (2), pp. 127-136.  show abstract

Luangdilok, S. Box, C. Harrington, K. Rhŷs-Evans, P. Eccles, S. (2011). MAPK and PI3K signalling differentially regulate angiogenic and lymphangiogenic cytokine secretion in squamous cell carcinoma of the head and neck. Eur j cancer, Vol.47 (4), pp. 520-529.  show abstract

Dwivedi, R.C. St Rose, S. Roe, J.W. Chisholm, E. Elmiyeh, B. Nutting, C.M. Clarke, P.M. Kerawala, C.J. Rhys-Evans, P.H. Harrington, K.J. Kazi, R. (2011). First report on the reliability and validity of speech handicap index in native English-speaking patients with head and neck cancer. Head neck, Vol.33 (3), pp. 341-348.  show abstract

Heinemann, L. Simpson, G.R. Boxall, A. Kottke, T. Relph, K.L. Vile, R. Melcher, A. Prestwich, R. Harrington, K.J. Morgan, R. Pandha, H.S. (2011). Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer. Bmc cancer, Vol.11, p. 9.

Ahmed, M. Barbachano, Y. Riddell, A. Hickey, J. Newbold, K.L. Viros, A. Harrington, K.J. Marais, R. Nutting, C.M. (2011). Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based population. Eur j endocrinol, Vol.165 (2), pp. 315-322.  show abstract

Brose, M.S. Nutting, C.M. Sherman, S.I. Shong, Y.K. Smit, J.W. Reike, G. Chung, J. Kalmus, J. Kappeler, C. Schlumberger, M. (2011). Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyroid cancer. Bmc cancer, Vol.11.

Bourke, M.G. Salwa, S. Harrington, K.J. Kucharczyk, M.J. Forde, P.F. de Kruijf, M. Soden, D. Tangney, M. Collins, J.K. O'Sullivan, G.C. (2011). The emerging role of viruses in the treatment of solid tumours. Cancer treatment reviews, Vol.37 (8), pp. 618-632.

Morgan, R. Michael, A. Bhatt, A. Harrington, K. Boxall, A. Annels, N. Pandha, H. (2011). Abstract 3100: HOX transcription factors promote cell survival in breast cancer. Cancer research, Vol.71 (8_Supplement), pp. 3100-3100.  show abstract

Sourisseau, T. Harrington, K.J. Muller, W.J. Marshall, C.J. White, D.E. (2011). Changes in tumor tissue organization in collagen-I sensitize cells to ionizing radiation in an ex vivo model of solid mammary tumor growth and local invasion. Cell cycle, Vol.10 (22), pp. 3979-3981.

Pedersen, J.V. Karapanagiotou, E.M. Biondo, A. Tunariu, N. Puglisi, M. Denholm, K.A. Sassi, S. Mansfield, D. Yap, T.A. De Bono, J.S. Harrington, K.J. (2011). A phase I clinical trial of a genetically modified and imageable oncolytic vaccinia virus GL-ONC1 with clinical green fluorescent protein (GFP) imaging. Journal of clinical oncology, Vol.29 (15).

Pedersen, J.V. Karapanagiotou, E.M. Biondo, A. Tunariu, N. Puglisi, M. Denholm, K.A. Sassi, S. Mansfield, D. Yap, T.A. De Bono, J.S. Harrington, K.J. (2011). A phase I clinical trial of a genetically modified and imageable oncolytic vaccinia virus GL-ONC1 with clinical green fluorescent protein (GFP) imaging. J clin oncol, Vol.29 (15_suppl), p. 2577.  show abstract

Steven, N.M. Harrington, K.J. Lee, L. Jia, H. Tanday, M.K. Roberts, C. Edwards, C. McGuigan, L. Hartley, A.G. Viskaduraki, M. Hui, E.P. Chan, A.T. Rickinson, A.B. Taylor, G.S. (2011). A UK-based phase I trial of recombinant modified vaccinia ankara (MVA) vaccine encoding Epstein-Barr virus (EBV) antigens. J clin oncol, Vol.29 (15_suppl), p. e13028.  show abstract

Steven, N.M. Harrington, K.J. Lee, L. Jia, H. Tanday, M.K. Roberts, C. Edwards, C. McGuigan, L. Hartley, A.G. Viskaduraki, M. Hui, E.P. Chan, A.T. Rickinson, A.B. Taylor, G.S. (2011). A UK-based phase I trial of recombinant modified vaccinia ankara (MVA) vaccine encoding Epstein-Barr virus (EBV) antigens. Journal of clinical oncology, Vol.29 (15).

Steele, L. Errington, F. Prestwich, R. Ilett, E. Harrington, K. Pandha, H. Coffey, M. Selby, P. Vile, R. Melcher, A. (2011). Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-kappa B mediated and supports innate and adaptive anti-tumour immune priming. Molecular cancer, Vol.10, p. 13.

Harrington, K.J. Billingham, L.J. Brunner, T.B. Burnet, N.G. Chan, C.S. Hoskin, P. Mackay, R.I. Maughan, T.S. Macdougall, J. McKenna, W.G. Nutting, C.M. Oliver, A. Plummer, R. Stratford, I.J. Illidge, T. (2011). Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers. Br j cancer, Vol.105 (5), pp. 628-639.

del Campo, J.M. Hitt, R. Sebastian, P. Carracedo, C. Lokanatha, D. Bourhis, J. Temam, S. Cupissol, D. De Raucourt, D. Maroudias, N. Nutting, C.M. Compton, N. Midwinter, D. Downie, L. Biswas-Baldwin, N. El-Hariry, I. Harrington, K.J. (2011). Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck. British journal of cancer, Vol.105 (5), pp. 618-10.

Charpidou, A. Gkiozos, I. Konstantinou, M. Eleftheraki, A. Demertzis, P. Harrington, K. Polyzos, A. Syrigos, K.N. (2011). Bronchial washing levels of vascular endothelial growth factor receptor-2 (VEGFR2) correlate with overall survival in NSCLC patients. Cancer letters, Vol.304 (2), pp. 144-10.

Kottke, T. Hall, G. Pulido, J. Diaz, R.M. Thompson, J. Chong, H. Selby, P. Coffey, M. Pandha, H. Chester, J. Melcher, A. Harrington, K. Vile, R. (2010). Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice. Journal of clinical investigation, Vol.120 (5), pp. 1551-10.

Hingorani, M. Spitzweg, C. Vassaux, G. Newbold, K. Melcher, A. Pandha, H. Vile, R. Harrington, K. (2010). The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery. Current cancer drug targets, Vol.10 (2), pp. 242-26.

Dandekar, P. Partridge, M. Kazi, R. Nutting, C. Harrington, K. Newbold, K. (2010). Challenges in integrating 18FDG PET-CT into radiotherapy planning of head and neck cancer. Indian journal of cancer, Vol.47 (3), pp. 260-7.

Khan, A. Smellie, J. Nutting, C. Harrington, K. Newbold, K. (2010). Familial Nonmedullary Thyroid Cancer: A Review of the Genetics. Thyroid, Vol.20 (7), pp. 795-7.

Harrington, K.J. Karapanagiotou, E.M. Roulstone, V. Twigger, K.R. White, C.L. Vidal, L. Beirne, D. Prestwich, R. Newbold, K. Ahmed, M. Thway, K. Nutting, C.M. Coffey, M. Harris, D. Vile, R.G. Pandha, H.S. Debono, J.S. Melcher, A.A. (2010). Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancers. Clin cancer res, Vol.16 (11), pp. 3067-3077.  show abstract

Powell, C. Mikropoulos, C. Kaye, S.B. Nutting, C.M. Bhide, S.A. Newbold, K. Harrington, K.J. (2010). Pre-clinical and clinical evaluation of PARP inhibitors as tumour-specific radiosensitisers. Cancer treatment reviews, Vol.36 (7), pp. 566-10.

Harrington, K.J. (2010). Topical treatment for oral cancers Winners and losers and oncolytic adenoviruses: who should be down in the mouth?. Gene therapy, Vol.17 (12), pp. 1421-2.

Heinemann, L. Simpson, G.R. Annels, N.E. Vile, R. Melcher, A. Prestwich, R. Harrington, K.J. Pandha, H.S. (2010). The Effect of Cell Cycle Synchronization on Tumor Sensitivity to Reovirus Oncolysis. Molecular therapy, Vol.18 (12), pp. 2085-9.

Bhide, S.A. Gulliford, S. Fowler, J. Rosenfelder, N. Newbold, K. Harrington, K.J. Nutting, C.M. (2010). Characteristics of response of oral and pharyngeal mucosa in patients receiving chemo-IMRT for head and neck cancer using hypofractionated accelerated radiotherapy. Radiotherapy and oncology, Vol.97 (1), pp. 86-6.

Hingorani, M. White, C.L. Zaidi, S. Pandha, H.S. Melcher, A.A. Bhide, S.A. Nutting, C.M. Syrigos, K.N. Vile, R.G. Vassaux, G. Harrington, K.J. (2010). Therapeutic Effect of Sodium Iodide Symporter Gene Therapy Combined With External Beam Radiotherapy and Targeted Drugs That Inhibit DNA Repair. Molecular therapy, Vol.18 (9), pp. 1599-7.

Harrington, K.J. Hingorani, M. Tanay, M.A. Hickey, J. Bhide, S.A. Clarke, P.M. Renouf, L.C. Thway, K. Sibtain, A. McNeish, I.A. Newbold, K.L. Goldsweig, H. Coffin, R. Nutting, C.M. (2010). Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck. Clinical cancer research, Vol.16 (15), pp. 4005-11.

Merron, A. Baril, P. Martin-Duque, P. de la Vieja, A. Tran, L. Briat, A. Harrington, K.J. McNeish, I.A. Vassaux, G. (2010). Assessment of the Na/I symporter as a reporter gene to visualize oncolytic adenovirus propagation in peritoneal tumours. European journal of nuclear medicine and molecular imaging, Vol.37 (7), pp. 1377-9.

Harrington, K.J. Nutting, C.M. (2010). Bravo for PRAVO. Lancet oncology, Vol.11 (5), pp. 407-2.

Bhide, S.A. Davies, M. Burke, K. McNair, H.A. Hansen, V. Barbachano, Y. El-Hariry, I.A. Newbold, K. Harrington, K.J. Nutting, C.M. (2010). WEEKLY VOLUME AND DOSIMETRIC CHANGES DURING CHEMORADIOTHERAPY WITH INTENSITY-MODULATED RADIATION THERAPY FOR HEAD AND NECK CANCER: A PROSPECTIVE OBSERVATIONAL STUDY. International journal of radiation oncology biology physics, Vol.76 (5), pp. 1360-9.

Ahmed, M. Schmidt, M. Sohaib, A. Kong, C. Burke, K. Richardson, C. Usher, M. Brennan, S. Riddell, A. Davies, M. Newbold, K. Harrington, K.J. Nutting, C.M. (2010). The value of magnetic resonance imaging in target volume delineation of base of tongue tumours - A study using flexible surface coils. Radiotherapy and oncology, Vol.94 (2), pp. 161-7.

Harrington, K.J. (2010). Rash conclusions from a phase 3 study of cetuximab?. Lancet oncology, Vol.11 (1), pp. 2-2.

Ismail, M. Morgan, R. Harrington, K. Davies, J. Pandha, H. (2010). Immunoregulatory effects of freeze injured whole tumour cells on human dendritic cells using an in vitro cryotherapy model. Cryobiology, Vol.61 (3), pp. 268-7.

Scott-Brown, M. Miah, A. Harrington, K. Nutting, C. (2010). Evidence-based review: Quality of life following head and neck intensity-modulated radiotherapy. Radiotherapy and oncology, Vol.97 (2), pp. 249-9.

Maughan, T.S. Illidge, T.M. Hoskin, P. McKenna, W.G. Brunner, T.B. Stratford, I.J. Harrington, K.J. Plummer, R. Billingham, L.J. Nutting, C. Burnet, N.G. Mackay, R.I. Oliver, A. Young, C. Chan, C.S. (2010). Radiotherapy Research Priorities for the UK. Clinical oncology, Vol.22 (8), pp. 707-3.

Bhide, S.A. Newbold, K.L. Harrington, K.J. Nutting, C.M. (2010). Combined chemotherapy and intensity-modulated radiotherapy for the treatment of head and neck cancers. Expert review of anticancer therapy, Vol.10 (3), pp. 297-4.

Sayed, S.I. Manikantan, K. Khode, S. Jagade, M. Kasbekar, V.G. Shah, R. Palav, R.S. Nutting, C.M. Harrington, K.J. Rhys-Evans, P. Kazi, R. (2010). Tracheo-oesophageal Party Wall Thickness in Laryngectomised Patients in India: Implications for Surgical Voice Restoration. Journal of surgical oncology, Vol.101 (1), pp. 78-6.

Harrington, K.J. Vile, R.G. Melcher, A. Chester, J. Pandha, H.S. (2010). Clinical trials with oncolytic reovirus: moving beyond phase I into combinations with standard therapeutics. Cytokine growth factor rev, Vol.21 (2-3), pp. 91-98.  show abstract

Dwivedi, R.C. St Rose, S. Roe, J.W. Khan, A.S. Pepper, C. Nutting, C.M. Clarke, P.M. Kerawala, C.J. Rhys-Evans, P.H. Harrington, K.J. Kazi, R. (2010). Validation of the Sydney Swallow Questionnaire (SSQ) in a cohort of head and neck cancer patients. Oral oncol, Vol.46 (4), pp. e10-e14.  show abstract

Dwivedi, R.C. Kazi, R. Agrawal, N. Chisholm, E. St Rose, S. Elmiyeh, B. Rennie, C. Pepper, C. Clarke, P.M. Kerawala, C.J. Rhys-Evans, P.H. Harrington, K.J. Nutting, C.M. (2010). Comprehensive review of small bowel metastasis from head and neck squamous cell carcinoma. Oral oncol, Vol.46 (5), pp. 330-335.  show abstract

Harrington, K.J. Kazi, R. Bhide, S.A. Newbold, K. Nutting, C.M. (2010). Novel therapeutic approaches to squamous cell carcinoma of the head and neck using biologically targeted agents. Indian j cancer, Vol.47 (3), pp. 248-259.  show abstract

Bhide, S.A. Kazi, R. Newbold, K. Harrington, K.J. Nutting, C.M. (2010). The role of intensity-modulated radiotherapy in head and neck cancer. Indian j cancer, Vol.47 (3), pp. 267-273.  show abstract

Powell, C. Newbold, K. Harrington, K.J. Bhide, S.A. Nutting, C.M. (2010). External beam radiotherapy for differentiated thyroid cancer. Clin oncol (r coll radiol), Vol.22 (6), pp. 456-463.  show abstract

Pencavel, T. Seth, R. Hayes, A. Melcher, A. Pandha, H. Vile, R. Harrington, K.J. (2010). Locoregional intravascular viral therapy of cancer: precision guidance for Paris's arrow?. Gene ther, Vol.17 (8), pp. 949-960.  show abstract

Roe, J.W. Carding, P.N. Dwivedi, R.C. Kazi, R.A. Rhys-Evans, P.H. Harrington, K.J. Nutting, C.M. (2010). Swallowing outcomes following Intensity Modulated Radiation Therapy (IMRT) for head & neck cancer - a systematic review. Oral oncol, Vol.46 (10), pp. 727-733.  show abstract

Morgan, R. Plowright, L. Harrington, K.J. Michael, A. Pandha, H.S. (2010). Targeting HOX and PBX transcription factors in ovarian cancer. Bmc cancer, Vol.10, p. 9.

Comins, C. Spicer, J. Protheroe, A. Roulstone, V. Twigger, K. White, C.M. Vile, R. Melcher, A. Coffey, M.C. Mettinger, K.L. Nuovo, G. Cohn, D.E. Phelps, M. Harrington, K.J. Pandha, H.S. (2010). REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer. Clinical cancer research, Vol.16 (22), pp. 5564-9.

Touchefeu, Y. Harrington, K.J. Galmiche, J.P. Vassaux, G. (2010). Review article: gene therapy, recent developments and future prospects in gastrointestinal oncology. Alimentary pharmacology & therapeutics, Vol.32 (8), pp. 953-16.

Kazi, R. Dwivedi, R.C. St Rose, S. Roe, J.W. Nutting, C. Rhys-Evans, P.H. Harrington, K.J. (2010). Validation of first speech-specific questionnaire for English-speaking head and neck cancer (HNC) patients. Journal of clinical oncology, Vol.28 (15).

Dwivedi, R.C. St Rose, S. Nutting, C. Rhys-Evans, P.H. Harrington, K.J. Kazi, R. (2010). A report on the development and validation of first-ever perceptual speech evaluation tool for head and neck cancer (HNC) patients. Journal of clinical oncology, Vol.28 (15).

Karapanagiotou, E.M. Chester, J.D. Pandha, H.S. Gill, G.M. Coffey, M.C. Mettinger, K. Harrington, K.J. (2010). A phase I/II study of oncolytic reovirus plus carboplatin/paclitaxel in patients with advanced solid cancers with emphasis on squamous cell carcinoma of the head and neck(SCCHN). Journal of clinical oncology, Vol.28 (15).

Harrington, K.J. Berrier, A. Robinson, M. Remenar, E. Housset, M. de Mendoza, F.H. Compton, N. Lau, M. Legenne, P. Kumar, R. (2010). Phase II study of oral lapatinib, a dual-tyrosine kinase inhibitor, combined with chemoradiotherapy (CRT) in patients (pts) with locally advanced, unresected squamous cell carcinoma of the head and neck (SCCHN). Journal of clinical oncology, Vol.28 (15).

Newbold, K. Castellano, I. Charles-Edwards, E. Mears, D. Sohaib, A. Leach, M. Rhys-Evans, P. Clarke, P. Fisher, C. Harrington, K. Nutting, C. (2009). AN EXPLORATORY STUDY INTO THE ROLE OF DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING OR PERFUSION COMPUTED TOMOGRAPHY FOR DETECTION OF INTRATUMORAL HYPOXIA IN HEAD-AND-NECK CANCER. International journal of radiation oncology biology physics, Vol.74 (1), pp. 29-9.

Willmon, C. Harrington, K. Kottke, T. Prestwich, R. Melcher, A. Vile, R. (2009). Cell Carriers for Oncolytic Viruses: Fed Ex for Cancer Therapy. Molecular therapy, Vol.17 (10), pp. 1667-10.

Kottke, T. Pulido, J. Thompson, J. Sanchez-Perez, L. Chong, H. Calderwood, S.K. Selby, P. Harrington, K. Strome, S.E. Melcher, A. Vile, R.G. (2009). Antitumor Immunity Can Be Uncoupled from Autoimmunity following Heat Shock Protein 70-Mediated Inflammatory Killing of Normal Pancreas. Cancer research, Vol.69 (19), pp. 7767-8.

Peerlinck, I. Merron, A. Baril, P. Conchon, S. Martin-Duque, P. Hindorf, C. Burnet, J. Quintanilla, M. Hingorani, M. Iggo, R. Lemoine, N.R. Harrington, K. Vassaux, G. (2009). Targeted Radionuclide Therapy Using a Wnt-Targeted Replicating Adenovirus Encoding the Na/I Symporter. Clinical cancer research, Vol.15 (21), pp. 6595-7.

Ismail, M. Morgan, R. Harrington, K. Davies, J. Pandha, H. (2009). Enhancing prostate cancer cryotherapy using tumour necrosis factor related apoptosis-inducing ligand (TRAIL) sensitisation in an in vitro cryotherapy model. Cryobiology, Vol.59 (2), pp. 207-7.

Prestwich, R.J. Errington, F. Diaz, R.M. Pandha, H.S. Harrington, K.J. Melcher, A.A. Vile, R.G. (2009). The Case of Oncolytic Viruses Versus the Immune System: Waiting on the Judgment of Solomon. Human gene therapy, Vol.20 (10), pp. 1119-14.

Prestwich, R.J. Errington, F. Steele, L.P. Ilett, E.J. Morgan, R.S. Harrington, K.J. Pandha, H.S. Selby, P.J. Vile, R.G. Melcher, A.A. (2009). Reciprocal Human Dendritic Cell-Natural Killer Cell Interactions Induce Antitumor Activity Following Tumor Cell Infection by Oncolytic Reovirus. Journal of immunology, Vol.183 (7), pp. 4312-10.

Pandha, H.S. Heinemann, L. Simpson, G.R. Melcher, A. Prestwich, R. Errington, F. Coffey, M. Harrington, K.J. Morgan, R. (2009). Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma. Clinical cancer research, Vol.15 (19), pp. 6158-9.

Prestwich, R.J. Ilett, E.J. Errington, F. Diaz, R.M. Steele, L.P. Kottke, T. Thompson, J. Galivo, F. Harrington, K.J. Pandha, H.S. Selby, P.J. Vile, R.G. Melcher, A.A. (2009). Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication. Clinical cancer research, Vol.15 (13), pp. 4374-8.

Nutting, C.M. van Herpen, C.M. Miah, A.B. Bhide, S.A. Machiels, J.-. Buter, J. Kelly, C. de Raucourt, D. Harrington, K.J. (2009). Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma. Annals of oncology, Vol.20 (7), pp. 1275-5.

Harrington, K.J. El-Hariry, I.A. Holford, C.S. Lusinchi, A. Nutting, C.M. Rosine, D. Tanay, M. Deutsch, E. Matthews, J. D'Ambrosio, C. Turner, S.J. Pandeshwara, J.S. Bourhis, J. (2009). Phase I Study of Lapatinib in Combination With Chemoradiation in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Journal of clinical oncology, Vol.27 (7), pp. 1100-8.

Ilett, E.J. Prestwich, R.J. Kottke, T. Errington, F. Thompson, J.M. Harrington, K.J. Pandha, H.S. Coffey, M. Selby, P.J. Vile, R.G. Melcher, A.A. (2009). Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity. Gene therapy, Vol.16 (5), pp. 689-11.

Bhide, S.A. Ahmed, M. Rengarajan, V. Powell, C. Miah, A. Newbold, K. Nutting, C.M. Harrington, K.J. (2009). ANEMIA DURING SEQUENTIAL INDUCTION CHEMOTHERAPY AND CHEMORADIATION FOR HEAD AND NECK CANCER: THE IMPACT OF BLOOD TRANSFUSION ON TREATMENT OUTCOME. International journal of radiation oncology biology physics, Vol.73 (2), pp. 391-8.

Agrawal, V.K. Copeland, K.M. Barbachano, Y. Rahim, A. Seth, R. White, C.L. Hingorani, M. Nutting, C.M. Kelly, M. Harris, P. Pandha, H. Melcher, A.A. Vile, R.G. Porter, C. Harrington, K.J. (2009). Microvascular free tissue transfer for gene delivery: in vivo evaluation of different routes of plasmid and adenoviral delivery. Gene therapy, Vol.16 (1), pp. 78-15.

Dandekar, P. Harmer, C. Barbachano, Y. Rhys-Evans, P. Harrington, K. Nutting, C. Newbold, K. (2009). Hyperfractionated Accelerated Radiotherapy (HART) for anaplastic thyroid carcinoma: toxicity and survival analysis. Int j radiat oncol biol phys, Vol.74 (2), pp. 518-521.  show abstract

Hoskin, P.J. Robinson, M. Slevin, N. Morgan, D. Harrington, K. Gaffney, C. (2009). Effect of Epoetin Alfa on Survival and Cancer Treatment-Related Anemia and Fatigue in Patients Receiving Radical Radiotherapy With Curative Intent for Head and Neck Cancer. Journal of clinical oncology, Vol.27 (34), pp. 5751-6.

Senzer, N.N. Kaufman, H.L. Amatruda, T. Nemunaitis, M. Reid, T. Daniels, G. Gonzalez, R. Glaspy, J. Whitman, E. Harrington, K. Goldsweig, H. Marshall, T. Love, C. Coffin, R. Nemunaitis, J.J. (2009). Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor-Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma. Journal of clinical oncology, Vol.27 (34), pp. 5763-9.

Manikantan, K. Khode, S. Sayed, S.I. Roe, J. Nutting, C.M. Rhys-Evans, P. Harrington, K.J. Kazi, R. (2009). Dysphagia in head and neck cancer. Cancer treatment reviews, Vol.35 (8), pp. 724-9.

Manikantan, K. Khode, S. Dwivedi, R.C. Palav, R. Nutting, C.M. Rhys-Evans, P. Harrington, K.J. Kazi, R. (2009). Making sense of post-treatment surveillance in head and neck cancer: when and what of follow-up. Cancer treatment reviews, Vol.35 (8), pp. 744-10.

Manikantan, K. Sayed, S.I. Syrigos, K.N. Rhys-Evans, P. Nutting, C.M. Harrington, K.J. Kazi, R. (2009). Challenges for the future modifications of the TNM staging system for head and neck cancer: Case for a new computational model?. Cancer treatment reviews, Vol.35 (7), pp. 639-6.

Kazi, R. Nutting, C.M. Rhys-Evans, P. Harrington, K.J. (2009). Significance and prognostic impact of comorbidity in head and neck cancer. Journal of cancer research and therapeutics, Vol.5 (3), pp. 145-3.

Nutting, C.M. Miah, A.B. Bhide, S. Urbano, M.T. Barbachano, Y. Newbold, K.L. Harrington, K.J. (2009). Dose-escalation Chemo-IMRT Improves Locoregional Control Rates in Organ Preservation Treatment of Locally Advanced Laryngeal and Hypopharyngeal Cancers. Clinical oncology, Vol.21 (8), pp. 646-2.

Sayed, S.I. Elmiyeh, B. Rhys-Evans, P. Syrigos, K.N. Nutting, C.M. Harrington, K.J. Kazi, R. (2009). Quality of life and outcomes research in head and neck cancer: A review of the state of the discipline and likely future directions. Cancer treatment reviews, Vol.35 (5), pp. 397-6.

Terpos, E. Kiagia, M. Karapanagiotou, E.M. Charpidou, A. Dilana, K.D. Nasothimiou, E. Harrington, K.J. Polyzos, A. Syrigos, K.N. (2009). The Clinical Significance of Serum Markers of Bone Turnover in NSCLC Patients: Surveillance, Management and Prognostic Implications. Anticancer research, Vol.29 (5), pp. 1651-7.

Kazi, R.A. Singh, A. Venkitaraman, R. Sayed, S.I. Rhys-Evans, P. Harrington, K.J. (2009). Is electroglottography-based videostroboscopic assessment of post-laryngectomy prosthetic speech useful. Journal of cancer research and therapeutics, Vol.5 (2), pp. 85-8.

Syrigos, K.N. Karachalios, D. Karapanagiotou, E.M. Nutting, C.M. Manolopoulos, L. Harrington, K.J. (2009). Head and neck cancer in the elderly: An overview on the treatment modalities. Cancer treatment reviews, Vol.35 (3), pp. 237-9.

Pandha, H. D'Ambrosio, C. Heenan, S. Hyde, N. Di Palma, S. Nutting, C. Relph, K. Harrington, K. (2009). Indium-labelled Autologous Dendritic Cells Migrate to Local Lymph Nodes after Intratumoural Injection in Head and Neck Cancer Patients. Clinical oncology, Vol.21 (4), pp. 363-2.

Plowright, L. Harrington, K.J. Pandha, H.S. Morgan, R. (2009). HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer). British journal of cancer, Vol.100 (3), pp. 470-6.

Kazi, R. Kanagalingam, J. Venkitaraman, R. Prasad, V. Clarke, P. Nutting, C.M. Rhys-Evans, P. Harrington, K.J. (2009). Electroglottographic and perceptual evaluation of tracheoesophageal speech. J voice, Vol.23 (2), pp. 247-254.  show abstract

Kazi, R. Rhys-Evans, P. Nutting, C.M. Harrington, K.J. (2009). The great debate: stroboscopy vs high- speed imaging for assessment of alaryngeal phonation. J cancer res ther, Vol.5 (2), pp. 121-123.  show abstract

Rogers, S.J. Box, C. Chambers, P. Barbachano, Y. Nutting, C.M. Rhŷs-Evans, P. Workman, P. Harrington, K.J. Eccles, S.A. (2009). Determinants of response to epidermal growth factor receptor tyrosine kinase inhibition in squamous cell carcinoma of the head and neck. J pathol, Vol.218 (1), pp. 122-130.  show abstract

Ross, P.J. Teoh, E.M. A'hern, R.P. Rhys-Evans, P.H. Harrington, K.J. Nutting, C.M. Gore, M.E. (2009). Epirubicin, cisplatin and protracted venous infusion 5-Fluorouracil chemotherapy for advanced salivary adenoid cystic carcinoma. Clin oncol (r coll radiol), Vol.21 (4), pp. 311-314.  show abstract

Zaidi, S.H. Huddart, R.A. Harrington, K.J. (2009). Novel targeted radiosensitisers in cancer treatment. Curr drug discov technol, Vol.6 (2), pp. 103-134.  show abstract

Bhide, S.A. Miah, A. Barbachano, Y. Harrington, K.J. Newbold, K. Nutting, C.M. (2009). Radical radiotherapy for treatment of malignant parotid tumours: a single centre experience 1995-2005. Br j oral maxillofac surg, Vol.47 (4), pp. 284-289.  show abstract

Clark, C.H. Miles, E.A. Urbano, M.T. Bhide, S.A. Bidmead, A.M. Harrington, K.J. Nutting, C.M. UK PARSPORT Trial Management Group collaborators, (2009). Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer. Br j radiol, Vol.82 (979), pp. 585-594.  show abstract

Dwivedi, R.C. Nutting, C.M. Rhys-Evans, P. Harrington, K.J. Kazi, R. (2009). Future perspectives for health related quality of life (HRQOL) studies in head and neck cancer. G ital med lav ergon, Vol.31 (3 Suppl B), pp. B17-B20.  show abstract

Dwivedi, R.C. Kazi, R.A. Agrawal, N. Nutting, C.M. Clarke, P.M. Kerawala, C.J. Rhys-Evans, P.H. Harrington, K.J. (2009). Evaluation of speech outcomes following treatment of oral and oropharyngeal cancers. Cancer treat rev, Vol.35 (5), pp. 417-424.  show abstract

Kazi, R. Nutting, C.M. Rhys-Evans, P. Harrington, K.J. (2009). A short perspective on the surgical restoration of alaryngeal speech. South med j, Vol.102 (8), pp. 838-840.  show abstract

Ismail, M. Bokaee, S. Davies, J. Harrington, K.J. Pandha, H. (2009). Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy. British journal of cancer, Vol.100 (12), pp. 1889-7.

Bhide, S.A. Miah, A.B. Harrington, K.J. Newbold, K.L. Nutting, C.M. (2009). Radiation-induced xerostomia: pathophysiology, prevention and treatment. Clin oncol (r coll radiol), Vol.21 (10), pp. 737-744.  show abstract

Kottke, T. Thompson, J. Diaz, R.M. Pulido, J. Willmon, C. Coffey, M. Selby, P. Melcher, A. Harrington, K. Vile, R.G. (2009). Improved Systemic Delivery of Oncolytic Reovirus to Established Tumors Using Preconditioning with Cyclophosphamide-Mediated Treg Modulation and Interleukin-2. Clinical cancer research, Vol.15 (2), pp. 561-9.

Bhide, S. Gulliford, S. A'Hern, R. Hall, E. Newbold, K. Harrington, K. Nutting, C. (2009). Quantitative estimates of the effects of concomitant chemotherapy on acute dysphagia in patients receiving radical treatment for head and neck cancer. J clin oncol, Vol.27 (15_suppl), p. e22134.  show abstract

Karapanagiotou, E. Pandha, H.S. Hall, G. Chester, J. Melcher, A. Coffey, M. de Bono, J. Gore, M.E. Nutting, C.M. Harrington, K.J. (2009). Phase I/II trial of oncolytic reovirus (Reolysin) in combination with carboplatin/paclitaxel in patients (pts) with advanced solid cancers. J clin oncol, Vol.27 (15_suppl), p. e14519.  show abstract

Saunders, M. Anthoney, A. Coffey, M. Mettinger, K. Thompson, B. Melcher, A. Nutting, C.M. Harrington, K. (2009). Results of a phase II study to evaluate the biological effects of intratumoral (ITu) reolysin in combination with low dose radiotherapy (RT) in patients (Pts) with advanced cancers. J clin oncol, Vol.27 (15_suppl), p. e14514.  show abstract

Nutting, C. A'Hern, R. Rogers, M.S. Sydenham, M.A. Adab, F. Harrington, K. Jefferies, S. Scrase, C. Yap, B.K. Hall, E. PARSPORT Trial Management Group, (2009). First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537). J clin oncol, Vol.27 (15_suppl), p. LBA6006.  show abstract

Harrington, K. Hingorani, M. Tanay, M. Matthews, J. Newbold, K. Renouf, L. Coffin, R.S. McNeish, I. Nutting, C. (2009). Phase I/II dose escalation study of OncoVex(GM-CSF) and chemoradiotherapy (CRT) in untreated stage III/IV squamous cell cancer of the head and neck (SCCHN). J clin oncol, Vol.27 (15_suppl), p. 6018.  show abstract

Nutting, C. A'Hern, R. Rogers, M.S. Sydenham, M.A. Adab, F. Harrington, K. Jefferies, S. Scrase, C. Yap, B.K. Hall, E. PARSPORT Trial Management Group, (2009). First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537; CRUK/03/005). J clin oncol, Vol.27 (18_suppl), p. LBA6006.  show abstract

Rudman, S.M. Comins, C. Mukherji, D. Coffey, M. Mettinger, K. Protheroe, A. Harrington, K.J. Pandha, H. Spicer, J.F. (2009). Results of a phase I study to evaluate the feasibility, safety, and biological effects of intravenous administration of wild-type reovirus with docetaxel to patients with advanced malignancies. J clin oncol, Vol.27 (15_suppl), p. e13524.  show abstract

Ahmed, M. Hansen, V.N. Harrington, K.J. Nutting, C.M. (2009). Reducing the risk of xerostomia and mandibular osteoradionecrosis: the potential benefits of intensity modulated radiotherapy in advanced oral cavity carcinoma. Med dosim, Vol.34 (3), pp. 217-224.  show abstract

Qiao, J. Kottke, T. Willmon, C. Galivo, F. Wongthida, P. Diaz, R.M. Thompson, J. Ryno, P. Barber, G.N. Chester, J. Selby, P. Harrington, K. Melcher, A. Vile, R.G. (2008). Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy. Nature medicine, Vol.14 (1), pp. 37-8.

Qiao, J. Wang, H. Kottke, T. White, C. Twigger, K. Diaz, R.M. Thompson, J. Selby, P. de Bono, J. Melcher, A. Pandha, H. Coffey, M. Vile, R. Harrington, K. (2008). Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus. Clinical cancer research, Vol.14 (1), pp. 259-11.

Kazi, R. Venkitaraman, R. Johnson, C. Prasad, V. Clarke, P. Newbold, K. Rhys-Evans, P. Nutting, C. Harrington, K. (2008). Prospective, longitudinal electroglottographic study of voice recovery following accelerated hypofractionated radiotherapy for T1/T2 larynx cancer. Radiotherapy and oncology, Vol.87 (2), pp. 230-7.

Comins, C. Heinemann, L. Harrington, K. Melcher, A. De Bono, J. Pandha, H. (2008). Reovirus: Viral therapy for cancer 'as nature intended'. Clinical oncology, Vol.20 (7), pp. 548-7.

Kottke, T. Diaz, R.M. Kaluza, K. Pulido, J. Galivo, F. Wongthida, P. Thompson, J. Willmon, C. Barber, G.N. Chester, J. Selby, P. Strome, S. Harrington, K. Melcher, A. Vile, R.G. (2008). Use of Biological Therapy to Enhance Both Virotherapy and Adoptive T-Cell Therapy for Cancer. Molecular therapy, Vol.16 (12), pp. 1910-9.

Yap, T.A. Brunetto, A. Pandha, H. Harrington, K. de Bono, J.S. (2008). Reovirus therapy in cancer: has the orphan virus found a home?. Expert opinion on investigational drugs, Vol.17 (12), pp. 1925-11.

Twigger, K. Vidal, L. White, C.L. De Bono, J.S. Bhide, S. Coffey, M. Thompson, B. Vile, R.G. Heinemann, L. Pandha, H.S. Errington, F. Melcher, A.A. Harrington, K.J. (2008). Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy. Clin cancer res, Vol.14 (3), pp. 912-923.  show abstract

Kazi, R. Singh, A. Al-Mutairy, A. De Cordova, J. O'Leary, L. Nutting, C. Clarke, P. Evans, P.R. Harrington, K. (2008). Electroglottographic analysis of valved speech following total laryngectomy. Logopedics phoniatrics vocology, Vol.33 (1), pp. 12-10.

Newbold, K.L. Partridge, M. Cook, G. Sharma, B. Rhys-Evans, P. Harrington, K.J. Nutting, C.M. (2008). Evaluation of the role of (18)FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer. Acta oncologica, Vol.47 (7), pp. 1229-8.

Singh, A. Kazi, R. Venkitaraman, R. Kapoor, K. Nutting, C. Clarke, P. Rhys, E.P. Harrington, K. (2008). Does flexible videostroboscopy compare with rigid videostroboscopy in the assessment of the neoglottis? A preliminary report. Clinical otolaryngology, Vol.33 (1), pp. 60-4.

Shears, L. Plowright, L. Harrington, K. Pandha, H.S. Morgan, R. (2008). Disrupting the Interaction Between HOX and PBX Causes Necrotic and Apoptotic Cell Death in the Renal Cancer Lines CaKi-2 and 769-P. Journal of urology, Vol.180 (5), pp. 2196-6.

Vidal, L. Pandha, H.S. Yap, T.A. White, C.L. Twigger, K. Vile, R.G. Melcher, A. Coffey, M. Harrington, K.J. DeBono, J.S. (2008). A phase I study of intravenous oncolytic reovirus type 3 Dearing in patients with advanced cancer. Clin cancer res, Vol.14 (21), pp. 7127-7137.  show abstract

Hingorani, M. White, C.L. Merron, A. Peerlinck, I. Gore, M.E. Slade, A. Scott, S.D. Nutting, C.M. Pandha, H.S. Melcher, A.A. Vile, R.G. Vassaux, G. Harrington, K.J. (2008). Inhibition of Repair of Radiation-Induced DNA Damage Enhances Gene Expression from Replication-Defective Adenoviral Vectors. Cancer research, Vol.68 (23), pp. 9771-8.

Errington, F. White, C.L. Twigger, K.R. Rose, A. Scott, K. Steele, L. Ilett, L.J. Prestwich, R. Pandha, H.S. Coffey, M. Selby, P. Vile, R. Harrington, K.J. Melcher, A.A. (2008). Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma. Gene therapy, Vol.15 (18), pp. 1257-14.

Hingorani, M. White, C.L. Zaidi, S. Merron, A. Peerlinck, I. Gore, M.E. Nutting, C.M. Pandha, H.S. Melcher, A.A. Vile, R.G. Vassaux, G. Harrington, K.J. (2008). Radiation-mediated up-regulation of gene expression from replication-defective adenoviral vectors: Implications for sodium iodide symporter gene therapy. Clinical cancer research, Vol.14 (15), pp. 4915-10.

Prestwich, R.J. Harrington, K.J. Vile, R.G. Melcher, A.A. (2008). Immunotherapeutic potential of oncolytic virotherapy. Lancet oncology, Vol.9 (7), pp. 610-3.

Errington, F. Steele, L. Prestwich, R. Harrington, K.J. Pandha, H.S. Vidal, L. de Bono, J. Selby, P. Coffey, M. Vile, R. Melcher, A. (2008). Reovirus activates human dendritic cells to promote innate antitumor immunity. Journal of immunology, Vol.180 (9), pp. 6018-9.

White, C